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                                         INTRODUCTION 
 
Siddha system of medicine is one of the ancient systems 
Contemporaneous with those of the submerged lands, Egyptian, 
Mesopotamian, Chinese and Grecian medicines. The unique nature of the 
system is its continuous service to humanity fore more then five thousand 
years in combating diseases, and in maintaining its physical, mental and 
mortal health. 
 
The Siddha medicine is well founded on the basic principles of 
nature and its elements after a careful and through study of the human 
system. 
 
      The ancient Tamil in their quest for knowledge for longevity had 
developed two ways, by which man can achieve mastery over nature; the 
one is the yogic way and other through medicines. Yogies is known as 
Siddhars. Hence the system of medicine profounded by them came to be 
known as siddha system of medicine.   
 
Siddha is a Tamil word that is derived from its root Siddhi – which 
means perfection in life or heavenly bliss. Siddhars attained eight kinds of 
supernatural powers.  The persons who had attained eight kinds of 
miraculous power in the life are known as Siddhars. 
 
The earliest medical treatise in Tamil was propounded by Sivanar, 
who was the first to preside over the ancient first Tamil academy.  It was 
followed by a number of works of immortal Siddhars. 
 
  Siddha system dealing not only science of life, nature of universe, 
astronomical data, cosmic dance, atomic theory,  space travel, alchemy 
and kayakalpa and medicines et. 
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Agastya siddhar who is the chief of the Siddhars’ school is said to 
have been a celebrated philosopher and physician who laboured amongst 
the Tamil in southern India.  
  
The man is said to be the microcosm and the world the macrocosm; 
because what exists in the world exist in man; or in other words there is 
nothing in the macrosom of nature that is not contained in man.  So man 
must be looked upon as an integral part of universal nature and not as 
anything separate or different from the latter. In the organism of man, these 
forces may act in an abnormal manner and cause diseases there by. 
Similarly, in the great organism of the cosmos, they may act abnormally 
likewise and bring about disease on earth. Seven planets exercise special 
power over some part of the body to cause diseases or diseases 
accordingly to their influences on the three humours in the system. 
 
The human body is composed ninety six thatwas or constituent 
principles in nature including elements, bodily and mental organs, faculties 
matter etc. 
 
The three humours are vadham, pittam and kabham. They are the 
three fundamental principles and essential factors in the composition and 
constitution of the human body. Three humours are representing 
respectively the air, the fire and the water of the five elements.  Which form 
the connecting link between microcosm or man and macrocosm or world? 
The external air, heat and water correspond to the internal vatham, pitham 
and kabam. 
 
Man is thus linked with external world and any change in the 
elementary condition of the external world has its corresponding changes in 
the human organ (humours). The normal order of vadham, pitham and 
kabam are in the proportion of 1: ½:¼ (4:2:1) respectively.   Any changes in 
this proportion are some to bring about disease or death.  But the 
maintenance of their normal proportion gives vitality of the organism and 
assures the prevention health and longevity of life. 
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The siddhars materia medica is based on human pathology.  It 
asserts that all substances of the animal, the herbs and the mineral 
kingdoms contain one or more of these three humous in their composition.  
They should plan on important role in the maintenance of these humours 
the men and women. Siddhars knowledge is on minerals, metals and 
plants suitable combination of these things on processing and the 
preparation of medicine.  According to the classification of the five elements 
of nature was of a very high order as can be learned from the lines of the 
ancient siddha medicine. 
 
Super intellectual siddhars devised and utilized special technique for 
diagnosis a disease known as envagai thervugal. These eight factors play 
a vital role in finding out disease and deranged life elements. 
 
Urinary calculus is known to mankind since antiquity. The earliest 
recorded example being bladder and kidney stones detected in Egyptian 
mummies dated to 4800 B C.  
 
Kalladaippu is most common disease of the present society Due to 
sedentary life style and abnormal diet habits. 
 
Clinical features of kalladaippu are lower abdomen pain, dysuria, 
oliguria, burning micturition, nusea, vomiting, haematuria and fullness of 
abdomen. 
 
In the contemporary world, till now no internal medicine is found for 
the renal calculus. In spite of new approach in diagnosis and management 
like Extra Corporeal Shock-wave Lithotripsy (E. C. S. L) and endoscopy 
surgery, but it still continues to cause significant morbidity with high 
tendency of reoccurrence and this kind of treatment procedure not reach to 
low socio economic status families, who are mostly affected renal calculus. 
 
The contribution of Yoogi in the field of regional and humoral pathology 
regarding the disease kalladaippu is highly commendable; Siddha 
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medicine is ancient duration system of medicine for centuries has provided 
proven treatment of disease like kalladaippu without morbidity.  
 
    We must praise, safe guard and follow the Siddha system of medicine 
and all so furnish it to take up with the up to date advancement. 
 
So the author of this dissertation work has selected kalladaippu 
under the neer arugal noi disease, expected by siddhar Yoogi in Yoogi 
vaithiya sindhamani perunool -800 and clinical entity comparable to 
urolithiosis in modern medicine. The drug kalladaippu thool was selected 
in Anupoga vaithiya navaneetham. 
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AIM AND OBJECTIVES 
 
The aim of this work is to select the case of kalladaippu patients 
and administer them with the trial drug, as per the line of treatment and 
analysis clinically and experimentally to prove efficacy of the drugs. Siddha 
literature revealed so many drugs for kalladaippu; among them the author 
has selected kalladaippu thool. 
 
  The main objective of the patient study is to create awareness about 
Siddha medicine and highlight the efficacy of Siddha medicine for the 
disease of kalladaippu among the public with basic intention in mind. The 
following specific objectives have been drawn. 
 
To collect and compare varies siddha and modern medicine. 
 
 To have an idea about incidence of kalladaippu with reference of 
age, sex, residence (Nilam), occurrence and duration of diseases.  
 
  To have a detailed study of investigation, diagnosis and prognosis of 
disease. 
 
  To study through investigation by Siddha fundamental and modern 
investigation during and after treatment in all patients. 
 
To study the urine analysis, hematological study and  
ultrasonography for all patients. 
 
 To study the biochemical analysis of trial drug. 
 
 To study pharmacological diuretic study and acute toxicity study of 
trial drug. 
 
 To conduct the clinical trial of kalladaippu thool on kalladaippu. 
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                           (KALLADAIPPU) 
 
The disease kalladaippu is placed under siruneer noi or moothira noi. 
Which is classified in to, 
 
1. Neerinai arukkal noi (Oligurial diseases) 
2. Neerinai perukkal noi (Polyurial diseases) 
3. Neerilivu, Venner and Thelimeer. 
This has been mentioned by Therayar in his ‘Theran karisal’ as follows 
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Kalladaippu is one of the Neerinai arukkal noigal 
Verupeyar (synonym): Achmari 
 

 (DEFINITION) 
 
According to the text Siddha maruthuvam by Dr. Kuppusamy. 
There is gradual or suddenly obstruction to the flow of urine, pain with 
burning sensation in the urethral tract, low back pain, renal angle pain, and 
sands like crystal’s deposit in urine. These are characteristic features of 
Kalladaippu.  
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Agasthiyar says the definition of kalladaippu as sand likes crystals 
deposited in urine, followed by small size of stones are excreted in urine. 
Stones are stagnated in kidney, ureter, urinary bladder and urethra. Pain 
with burning sensation start in urethral orifice followed to agonizing pain 
occurs during the stone moving in urethral tract from the bladder, when the 
stone removed pain also relieved.  
 
Large concentration of minerals in the bladder or kidney produces 
calculus or gravel. It is altered with difficulty in passing in urine. 
 
                                     -  T. S. Sambasivam Pillai. 
 
Kalladaippu is defined as pain in and around the umbilicus, fever, 
dysuria and urine smelling like that of goat’s urine. 
  -  Jeevanachamirtham. 
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NOI VARUM VAZHIKAL (AETIOLOGY) 
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Stone formed by derangement of humours of vatham and pittam.  
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It is worth while to mention the poem of Yoogimamunivar who is 
authority of Siddhars regional and humoral pathology. He has revealed 
about this disease since 14th century.  
  Yoogimamunivar says that as blood clotted in urinary bladder due to 
urinary tract diseases followed by swelling of urinary bladder, urinary 
stones are formed in urinary tract induced by humour of vatham and 
pittham.  
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In this explains that mind plays a major role in causing many 
diseases and connection between body and mind and soul is established 
i.e., the mukkutram deranged by internal factors such as sexual perversion, 
anger and robbery. 
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The causes mentioned here, 
• Contaminated water 
• Stone crystals, bone, hair and sand mixed food. 
• Decayed food 
• Carbohydrate food 
• Humour of vali induced food 
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Siddha maruthuva surukkam explained that urination is one of the 
14 visceral reflexes. When one suppress this visceral reflex it lapses into 
manifestation of morbidity, which comprises inflammation of bladder, 
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anuria, arthralgia, pain in genital region and deranged of keezh nokkukaal. 
This leads to the formation of calculus. 
      
The author also explain that ejaculation of semen is one of the 14 
visceral reflexes when one suppress this reflex it causes fever, retention of 
urine which favours urinary calculi, chest pain, arthralgia, and white 
discharge. 
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According to noi vilakkam 
• Derangement if humour in blood, 
• Exessive indulgence in sexual activity or sexual pervertion, 
• Trauma on testes, 
• Suppression of urine and semen 
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• Inflammation of bladder 
• Syphilis (Mega noi) 
• Stagnation of urine in urinary tract. 
• Dryness of semen causes the formation of stones. 
•  Increased intake of food that cause flatulence. 
 
POTHU KURI KUNANGAL 
 
• Gradual or sudden obstruction to flow of urine, 
• Unbearable pain(agonizing pain) in the penis 
• Excruciating pain and swelling is experienced at tip of penis if the 
calculus attempts to expel. 
• Colicy pain radiating from loin to groin, lower abdomen, urethra and 
genitalia if the calculus is irregular with sharp projection. 
• Burning and scanty micturation and haematuria.   
 
SYNDROMES ASSOCIATED WITH KALLADAIPPU  
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 Excessive growth of muscles in chest region, back of trunk, 
umbilicus and anal and urethral orifice followed by stricture of urethral 
orifice like a sand like crystals blocked in urethra. Dysuria, body pain, 
impairment of conscious, tiredness, and giddiness occurs. 
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CLASSIFICATION OF KALLADAIPPU 
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The most experienced of Siddhars, Yoogimamunivar who has 
studied the disease according to regional and humoral pathology classifies 
kalladaippu in to 4types there are 
 
    1.  	!<,       2.  	!<,        3. J 	!<,     
    4. 8* 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1. 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• Retention of urine. 
• Lower abdomen pain.  
• Pain with swelling of penis. 
• Agonizing pain. 
• Breathlessness. 
• Abdomen distention. 
• Excretion of urine with mucus. 
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2.   (AZHAL KALLADAIPPU)  
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• Stone blocked in urinary tract followed by oliguria. 
• Pain in urethra like an insertion of burning iron bar, followed       
      by sweating all over body. 
• Anuria, Agonizing pain. 
• Blood stained calculus stagnated in urethra followed by                             
piercing and boring pain with sensitiveness. 
 
3.  
  (IYYA KALLADAIPPU) 
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• Abdomen distention like a bow with pain. 
• Pain in all joints of upper and lower limb and hip joints. 
• Pain in penis, sweating all over body. 
• White coloured stone excreted in urine. 
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4.   (MUKKUTTRA KALLADAIPPU) 
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• Severe pain in urethra.  
• Dysuria. 
• Oliguria. 
• Crystals excreted in urine like a small sands. 
• Handful crystals excreted in urine daily. 
• It is fatal disease. 
 
CLSSIFICATION IN DHANVANTHIRI VAITHIAM 
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  In Thanvanthiri vaithiyam, kalladaippu is classified to four types they are  
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• Increased iyyam and azhal kutram dries the urine and 
semen forming calculi 
• Sudden or gradual obstruction in urinary tract 
• Dysuria 
• Pain in umbilicus 
• Fever 
• Anorexia. 
    "#$% &'% (SILETHUMA ACHMARI) 
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• Calculus in the Ureter or urethra causes hydronephrosis 
• Oliguria, 
• Reddish white in colour and falls out like semen 
• Stones are expelled as 4 or 8 fragments. 
 
     &'% (PITHA ACHMARI)  
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• Burning sensation in urethra due to azhal kutram 
• Burning micturition  
• Formation of stone that appear like semicarpus anacardium seeds. 
 
  ( &'% (SUKKILA ACHMARI) 
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• Suppressions of semen during ejaculation, develops on to stones 
and obstruction in the flow of urine 
• Sand like gravels are expelled 
• Pallor of the body. 
• This is incurable. 
 
CLASSIFICATION ACCORDING TO NOI VILAKAM 
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There are four types of kalladaippu according to noi vilakkam  
 
1. Vali kalladaippu, 
2. Analakalladaippu, 
3. Iyya kalladaippu,  
4. Karuneer kalladaippu  
 
) (VALI KALLADAIPPU) 
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• Tongue biting , palpitation and shivering, 
• Crushing of the lower abdomen and genital organs 
• Dribbling of urine. 
• The stones are blackish red colour. 
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  &* (ANALA KALLADAIPPU) 
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• Burning micturition, 
• Dysuria, 
• The stones are reddish black or yellow in colour and  
passing of smalls stones 
 

 (IYYA KALLADAIPPU)  
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• Pricking pain, forceful pain with severe intensity when passing urine, 
• Fever with rigors, 
• White or honey coloured shining or luminant large size stone 
expelled. 
 
     +,-.  (KARUNEER KALLADAIPPU) 
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• Sudden or gradual obstruction to flow of urine, 
• Swelling of testis, 
• Excessive vali kutram breaks the stones into small and large size 
crystals and expels along with urine. 
• Sudden stoppage of urine stream, 
• Retention of urine, 
• Abdominal pain, 
• Loss of taste excessive thirst, 
• Pricking pain with swelling of abdomen and testis, 
• Retention of urine or anuria may leads to renal failure and fatal 
 
Classification in Jeevaratchamirtham and Anubhava 
vaithiya devaragasium: 
 
Fives types 
 
1. Vatha achmari, 
2. Pitha achmari, 
3. Kabha achmari, 
4. Shukila achmari, 
5. Swargara achmari. 
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Classification of disease in Indian medicine     
-By Dr. Juliusjully 
Four types; 
1. Vatha achmari, 
2. Pitha achmari, 
3. Kabha achmari, 
4. Shukila achmari. 
 
Classification in siddhar aruvai maruthuvam- four types: 
1. Vali kalladaippu,  
2. Azhal kalladaippu, 
3. Iyya kalladaippu, 
4. Venneer kalladaippu. 
 
MUKKUTRA VERUPADUKAL (PATHOLOGY) 
 
The imbalance in one’s diet and fluid intake increases the 
Azhalkutram. This raised kutram dries up the body fluid and urine resulting 
in concentration of salts; this further affects the keezh nokku kaal. One of 
the functions of the keezh nokku kaal is to excrete urine. So when this 
keezh nokkukaal is affected urine will be obstructed within urinary tract. 
This favors the deposition of urinary salts to develop in to calculi any where 
in the kidney or urinary tract.  
 
#,/ 0  (DIAGNOSIS AND PROGNOSIS) 
In piniyarium muraikal the following principles are followed in Siddha 
system. There are  
 1.*"$, 
 2.<
, 
 3. 
. 
 
The maruthuvar (physician) should observe the patient, palpate and 
interrogate the patient thoroughly. This is stressed also understood by this 
maxim.  
“Eyes first and most, Hands next and little, mouth last and never” 
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I, II, PORIYAL ARITHAL AND PULANAL ARITHAL 
 
Poriyal arithal or understanding by the five organs of perception. 
Pulanal arithal or understanding by the sense objects. There are 
  
1. Mei-      Ooru (Somatic sense) 
2. Vaai –   Suvai (Taste) 
3. kan –     Oli (Vision) 
4. Mookku – Natram (Smell) 
5. Sevi – Oosai (Sound) 
 
1. * (INTEROGATION)  
 
An effective history taking helps one to diagnosis properly. By 
vinathal the physician should ask the patients native place, mode of living, 
food habits, personal habits, complaints and duration of illness etc. If the 
patient is deaf or dump or if the patient is a child, the particulars should be 
obtained from his relatives or parents. 
Poriyal arithal, pulanal arithal and vinathal are applied through eight special 
tools of investigation that is envagai thervugal. 
 
ENVAGAI THERVUGAL 
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NAADI 
The word pulses means the beating of artery felt with the tip of the 
fingers, its rate and character go to indicate a person’s condition of health. 
It is also understood as the beating, throbbing or rhythmical dilatation of 
arteries as the blood is propelled along them by the contraction of the heart 
in the living body. The term pulse in medical practice is usually applied to 
beat or throb felt in radial artery at the wrist; through it may felt over the 
temporal, carotid, ulnar, brachial, femoral and other artery. 
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Normally the pulse is recorded in the radial artery in the right hand for the 
male and left hand for the female by keeping the index finger, the middle 
finger and the ring finger on it after gently scrubbing the area. It is one unit 
in vali as felt by index finger and a half unit in azhal as belt by the middle 
finger and one fourth units in iyya as felt by the ring finger. The different 
diseases could easily be diagnosed with aid of the pulse.  
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Aggravation of valinadi produces symptoms of kalladaippu. This is 
emphasized in Agathiar nadi, Sathaga nadi and Rathina churukkanadi.     
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Aggravation of azhal nadi produces symptoms of kalladaippu, 
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Derangement of vali-azhal naadi produces symptoms of kalladaippu.        
         
            '
  C "$0 
                  0 ,' 8P;  
             	/ <'" / * 
                 </ -# %!( 
                                          - - 
2"3 
 
By sparism the temperature of skin (thatpam-cold or veppam-heat), 
smoothness, roughness, sweating, dryness, hard patches, swelling, 
abnormal growth of organs and tenderness can be felt. 
 
In Kalladaippu patients tenderness over the lower abdomen, renal 
angle and lumbar region, swelling can be felt in valikalladaippu (may be 
due to hydronephrosis) 
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Also patient’s temperature is increased in lower abdomen and in 
ayyakalladaippu, sweating all over the body at the time of colic. 
 
, (Tongue) 
   By the examination of the tongue its colour, size, shape, coating, 
moisture, movement, ulcer, fissures, crust and condition of teeth and gums 
can be examined. In kalladaippu if there is constipation (valikalladaippu), 
the tongue would seem to be coated. Loss of taste in karuneer kalladaippu. 
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,3 (Colour) 
Colour of the skin all over body, a local region of affection in conjuntiva, 
tongue, nail bed and hair etc. 
 
Vali udal-      Block colour, 
Azhal udal-   Yellow or red colour, 
Iyya udal –    White or yellow 
In kalladaippu niram of udal depends up on the body constitution, 
pallor of the body is observed in sukkila ashmari. 
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 %4 (Speech) 
By examining mozhi (speech), characters, hoarseness, slurring 
speech, various disorders of speech such as dysarthria can be noted. In 
kalladaippu there is low pitch voice due to agonizing pain in lower 
abdomen and burning sensation.   
 
4 (Eye) 
Examine the colors of eye - like reddish or yellowish discoloration 
and characters like dryness and lacrimation. Tiredness and redness due to 
pain is observed in patients with renal colic. In addition one has to be 
 24 
examine the patients acquits, there may be pallor of eyes due to gross 
haematuria.  
%3 (Stools) 
By examining malam, its nature, colour, quantity and presence of 
blood or pus can be noted. In valikalladaippu constipation and oliguria will 
be present. 
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,-. (Urine examination) 
Urinary examination is good diagnosis method compare to  
naadi and other Envagai thervugal. Theraiyar mention below as     
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Siruneer should be collected in early morning; patient should be 
eating six tastes of food with regular time and well sleeping over night, 
urine should be examine with in 3¾hrs. This is quoted as  
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Siruneerin pothugunam: 
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1. Niram (Color), 2. Eadai (Specific gravity), 3. Nurai (Froth), 4. Natram 
(Smell), 5. Enjal (Deposits).  
 
Above the five parameters by which each urine sample should be 
examined. 
 
NIRAM (COLOUR) 
NIRA THOGAI 
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1. Yellow, 
2. Red, 
3. Green, 
4. Block, 
5. White. 
Urine may be any colour mention above. 
 
  ,-! 03 (COLOUR INDICATING URINARY 
STONES) 
The urine colour would look like flesh washing water this is indicated 
in kidney diseases. 
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EADAI (SPECIFIC GRAVITY) 
Urine not thick is considered healthy.  
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NURAI (FROTH) 
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Urine may be frothy in nature, if it is reduced in vali, azhal and 
ayyam are said to be deranged. 
 
NATRAM (SMELL) 
 
                     %003 
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Foul odour with pyuria is observed in patients with urinary lithiasis 
associated with urinary tract infection and ulcer.   
 
ENJAL (DEPOSITS) 
If urine excretion look like curd water white color and sand like 
deposits in urine indicate stones in kidney. This mention as  
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NEI KURI 
The urine kept on the kidney tray in sun light, on non wind condition, should 
be examined by dropping a drop of gingili oil gently with rod. If oil spread 
like snake it indicates valineer, a ring indicates azhal neer, and a float like a 
pearl it indicates iyya neer and sinks in urine indicates mukkutram. 
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In kalladaippu patients, oil spreading like ring indicates Azhal neer or 
snake indicates Vali neer. 
 
"
3, &"
3 (PROGNOSIS) 
 
             %- 	  "'2 
                     B=  	!< 
              E%-%!  	!< 
                    <
"%&/ 	!< 
              8%-%! + / 
                    8	

 /0'* 	/  
              "%-%! 0/,  	!< 
                    &B" #/ D%0 "
( 
 28 
According to Yoogimamunivar, Vali, Azhal, and Ayya kalladaippu are 
curable where as Mukkutra kalladaippu is in curable. 
 
 
 
%+$3 (LINE OF TREATMENT) 
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The main object of treatment is to bring down the deranged mukkutrams to 
natural equilibrium by giving pugatives, which cure derangement of vatham, 
this one of the cause for kalladaippu. 
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  As per the above mention, author gives purgation to all patients as 
their body condition.The author of dissertation has selected trial drug 
Kalladaippu thool, dose of 5gms two times per day with raddish juice for 2 
months period.       
 
  In siddha system treatment is not only for removable of disease but 
the prevention and improving the body condition after removal of disease. 
This is said as kappu, neekkam and thiraippu. 
 
DIET 
 
     All patients are strictly advised to follow this diet restriction as highly 
calcium and oxalate diet likes cabbage, cauliflower, tomato, pees, 
cashionuts, almonds, grapes, strawberry, pine apple, tea and coffee. 
Calcium and protein diet likes milk, milk products and non vegetarian foods.  
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URINARY CALCULUS 
 
 PHYSIOLOGICAL ANATOMY OF THE KIDNEY 
   The kidneys are two bean shaped organs situated retroperitoneal, 
one on the either side on the posterior abdominal wall. Each kidney weighs 
about 120 to 150gms and is enclosed in thin but tough fibrous capsules, 
and concave medial side of the kidney is the hilum where the renal artery 
enters and renal vein and ureter leave the kidney. The components of 
kidney are arranged in three layers. 
 
1. Outer cortex 
 This is dark and granular appearance. It contain renal capsules and 
convoluted tubules, at intervals cortical tissues penetrate medulla in this 
form of columns is called column of Bertini. 
 
2. Inner medulla 
  This gives radially striated appearance as it contains tubular and 
vascular structures. Medulla mass is divided in to 8 to 18 medullary or 
malpighian pyramids, the base of pyramids and are connect with cortex 
and apex projects in to minor calyx. 
 
3. Renal sinus 
   It consist upper expanded part of ureter called renal pelvis, it 
subdivided into about 8 minor calyces, and branches of nerves, arteries, 
and tributary vein and loose connective tissues and fat. 
Nephron 
 Structural and functional unit of the kidney is nephron. Each kidney 
has a million nephrons. Each nephron begain in cortex as  
• A funal like dilatation called the Bowman’s capsule, which enclose a 
tuft of capillaries the glomerulus.The Bowman’s capsule together 
with the glomerulus is called the Malpighian corpuscle or Renal 
corpuscle. 
• The renal tubule leaves the Bowman’s capsules and becomes 
convoluted to form of the proximal convoluted tubule (PCT). 
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• It then becomes straight and passes down it the medulla as the 
descending limb of the loop of the Henle, after varying distances 
before reaching the end of the papilla, it turns round in the form a U-
shaped bend, forming loop of Henle, and passes upward towards 
the cortex, parallel with its former course as the ascending limb of 
the loop of Henle. Each limb has an outer thick and inner thin 
portion.  
 
• Thick ascending limb approaches its own, glomerulus, and contact 
with the afferent and efferent arterioles to form the juxtaglomerular 
apparatus. It then becomes convoluted to form the distal convoluted 
tubule. 
 
• The DCT then straightens out and joins by short connecting ducts to 
form the collecting tubules or collecting ducts (CD). They unit to form 
larger collecting ducts and descent parallel to loop of Henle and 
open in the papilla or the duct of bellini in the renal pelvis. The length 
of the nephron varies from 4 to 6.5cms. 
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  RENAL CIRCULATION 
 
   Renal artery arises from the aorta, enters the kidney at the hilum 
and divided in to an anterior and a posterior branch, which give rise the 
about five segmental arteries. The segmental artery divided into 
interlobararteries, which pass outward in the medulla between the pyramids 
to reach boundary zone between the medulla and cortex. Here they turn to 
take a horizontal course uniting with adjacent arteries to form arterial 
arches called arcuate arteries. Several straight arteries arise from these 
arches and run radially outward through the cortex. These are called inter 
lobular arteries. From each interlobular artery, numerous afferent arteries 
arise, and enter the Bowman’s capsule forming glomerular capillary tuft. 
The afferent arterioles divide in to 4 to 5 large capillaries. Each large 
capillary divided in to small capillaries, which form the loop, and capillary 
loop unit to form the efferent arteriole, which leaves the Bowman’s capsule. 
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The efferent arterioles give rise to renal portal system. The efferent 
arterioles form a second capillary net work surrounding the tubular portion 
of the nephron; the capillaries of second set are called peritubular 
capillaries. 
 
The tubular portion of juxtamedullary nephron is supplied by some 
specialized peritular capillaries called Vasarecta. Vasarecta arise directly 
from the efferent arteriole of the juxtamedullary nephrons. The peritubular 
capillaries drain in to the venous system, which include the peritubular 
venules, interlobular veins, segmental vein and finally the renal vein 
 
URINE FORMATION 
 
Kidney excreted the unwanted substances including metabolic end 
products and those substances, which are present in excessive quantities 
in body, through urine. Normally about 1 to 1.5 litters of urine is formed 
every day. The mechanism of urine formation includes various processes. 
First, when blood passes through glomerular capillaries, the plasma filtered 
in Bowman capsule, when this filtrate passes through the tubular portion of 
nephron, it undergoes varies changes both in quality and in quantity, many 
wanted substances like glucose, aminoacid, water and electrolytes are 
reabsorbed from the tubules, this process is called  tubular reabsorption . 
And some unwanted substances are secreted in to the tubule from 
peritubular blood vessels. This process is called tubular secretion. The 
urine formation includes three processes. 
1. Glomerular filtration 
2. Tubular reabsorption  
3. Tubular secretion 
 
1. GLOMERULAR FILTRATION 
When blood passes through the glomerular capillaries the plasma 
filtered in to the Bowmans capsule. All the substances of plasma are 
filtered except plasma proteins. The filtered fluid is called Glomerular 
filtrate. During filtration the substances passes through a three layer of 
filtrating membrane such as  
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1. The endothelium of capillary membrane, 
2. Basement membrane and  
3. Endothelium of visceral layer of Bowmen capsule. 
 
The glomerular filtration is called ultra filtration because minute 
particles are filtered, but the plasma proteins are not filtered due to larger 
molecular size than size of the slit pores. The composition glomerular 
filtrate is similar to that of plasma except in the absence of plasma proteins.  
Glomerular filtrate rate GFR 
 The total quantity of filtrate formed in all the nephron of both the 
kidneys in the given unit of time is called glomerular filtrate rate.  The 
normal value of glomerular filtrate rate is 125 ml / minute or about 180  
litres / day. 
Filtration Fraction 
 The fraction of the renal plasma which becomes the filtrate is called 
filtration fraction.  It is the ratio between renal plasma flow and glomerular 
filtrate.  It is expressed in percentage. 
 They filtration fraction =                   GFR            ×    100 
                                                          Renal plasma flow 
 
                                                 =       125 ml / minute ×100 
                                                          650 ml / minute 
 
                                                  =       19.2% 
The normal filtration fraction values from 15 to 20% 
 
Pressure determining filtration: 
 Glomerular capillary pressure, colloidal osmotic pressure in the 
glomeruli and the hydrostatic pressure in the Bowman’s capsule, which are 
determine the GFR.  Among these pressures, the glomerular capillary 
pressure favours filtration the glomerular capillary pressure is about 60mm 
Hg and is highest capillary pressure in the body.  The colloidal osmotic 
pressure and hydrostatic pressure oppose the filtration.  The colloidal 
osmotic pressure exerted by plasma protein in the glomeruli.   The plasma 
proteins are not filtered through the glomerular capillaries, so increased 
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concentration of proteins in glomerulus during filtration causes the 
development of colloidal osmotic pressure. It is about 25mmHg. Hydrostatic 
pressure in Bowman’s capsule is exerted by the filtrate in Bowman’s 
capsule during filtration.  It is about 15mmHg. 
 
Net filtration pressure: 
 
 The balance between pressure favoring filtration and pressures 
opposing filtration is called net filtration pressure. This is very essential for 
the maintenance of GFR so this is otherwise known as effective filtration 
pressure of essential filtration pressure. 
 The net filtration pressure = Glomerular capillary pressure – colloidal 
osmotic pressure + Hydrostatic pressure in Bowman’s capsule  
                                          =   60 – (25+15) = 20mmHg 
 The normal net filtration pressure is about 20mmhg and it varies 
between 15 and 20mmHg 
 
Factors regulating GFR: 
Following are the various factors, which regulate or affect the GFR 
 
1. Tubular glomerular feedback mechanism 
This is the process in which the GFR is constantly regulated by 
means of feed back form renal tubule. The macula densa of 
juxtaglomerular apparatus is responsible for this. When the glomerular 
filtrate passes through the end portion of thick ascending segment of renal 
tubule, the macula densa detects the concentration of sodium chloride and 
accordingly alters the GFR.  It the concentration of sodium chloride is more, 
macula densa causes constriction of afferent arteriole and filtration rate 
decreases, the constriction of afferent arteriole may be due to the secretion 
of thromboxane A2 from macula densa. 
 
2.  Glomerular capillary pressure 
 The GFR is directly proportional to glomerular capillary pressure.  
When glomerular capillary pressure is increased the GFR is also increased, 
in turn depends upon the renal blood flow 
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3. Colloidal osmotic pressure 
The GFR is inversely proportional to colloidal osmotic pressure 
exerted by protein.  During dehydration or increased plasma protein level, 
colloidal osmotic pressure is more and GFR is reduced. 
 
4. Hydrostatic pressure in Bowman’s capsule 
  GFR is inversely proportional to this.  The hydrostatic pressure in 
Bowman’s capsule is increased in conditions like obstruction of urethra and 
oedema of kidney beneath renal capsule. 
 
5. Renal blood flow 
This is the most important factor necessary for glomerular filtration.  
And, the GFR is directly proportional to this. 
 
6. Constriction of afferent arteriole 
This reduces the blood flow to the glomerular capillaries and this in 
turn reduces GFR. 
 
7. Constriction of efferent arteriole 
It efferent arteriole is constricted; initially there is an increase in GFR. 
 
8. Systemic arterial pressure 
However, increase in mean arteriole pressure up to 180mmHg or 
reduction up to 60mmhg does not alter renal blood flow or GFR. This is due 
to auto regulatory mechanism.  Variation in pressure above 180mmHg or 
below 60mmHg affects the renal blood flow and GFR because auto 
regulating mechanism fails beyond this range. 
 
9. Sympathetic stimulation 
The mild or moderate stimulation of sympathetic nerves does not 
causes any significant change either in renal blood flow or in GFR.  This is 
due to auto regulation.  Strong sympathetic stimulation causes severe 
constriction of the blood vessels needs to increase filtration initially, but 
latter decreases. 
10. Surface area of capillary membrane 
GFR is directly proportional to the surface area of the capillary membrane. 
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Tubular reabsorbion 
  When the glomerular filtrate passes through the tubular portion of 
nephron, both quantitative and qualitative changes occur.  Large quantity of 
water, electrolytes and other substances are reabsorbed by the tubular 
epithelial cells.  The substances, which are reabsorbed, pass in to the 
interstitial fluid of renal medulla, and from here, the substances more in to 
the blood in peritubular capillaries.  As the substances are taken back in to 
the blood, the entire process is called tubular reabsorption. 
 
Selective reabsorbtion 
   The tubular cells of kidney selectively reabsorb the substances 
present in the glomerular filtrate, according to the needs of the body. So the 
tubular reabsorption is called the selective absorption.  Depending upon the 
degree of reabsorption, the various substances are classified into three 
categories. 
 
1) High threshold substances 
The food substances like glucose, amino acid, acetoacetate ions 
and vitamins are completely reabsorbed do not appear in urine under 
normal condition.  These substances appear in urine, only if their 
concentration in plasma is abnormally high or in renal diseases.  So these 
substances are called high threshold substances. 
 
2) Low threshold substances 
The substances such of urea, uric acid and phosphate are 
reabsorbed to little extend.  These substances appear in urine even under 
normal conditions.  Such substances are known as low threshold 
substances. 
 
3) Non threshold substances 
The metabolic end products like creatinine are not at all reabsorbed 
and are excreted in urine irrespective of their plasma level.  These 
substances are called non threshold substances. 
Mechanism of reabsorption 
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The mechanisms involved in tubular reabsorption are of two types 
1. Active reabsorption and 
2. Passive reabsorption. 
 
1. Active reabsorption 
 The movement of molecules is against the electrochemical gradient.  
This needs liberation of energy.  And the energy is derived from ATP.  The 
substances reabsopped actively from the renal tubule are sodium, calcium, 
potassium, phosphates, sulphates, bicarbonates, glucose, amino acids, 
ascorbic acid, uric acid and ketone bodies. 
 
2. Passive reabsoption 
 In this process, the movement of molecules is more along the 
electrochemical gradients. This process does not need energy, the 
substances reabsorped by passive transport are chloride, urea, and water. 
 
 
Site of reabsorption 
 Substances reabsorbed from proximal convoluted tubule.  Glucose, 
amino acids, sodium, potassium, calcium, bicarbonates, chlorides, 
phosphates, uric acid and water are reabsorbed from proximal convoluted 
tubule. The substances reabsorbed from loop of Henle are sodium chloride.  
The substances reabsorbed from distal convoluted tubule are sodium, 
bicarbonate and water. 
 
Tubular secretion 
 Some substances secrete in to the lumen from the peritubular 
capillaries through the tubular epithelial cells. These known as tubular 
secretion or tubular excretion. 
 
1. Potassium is secreted actively by sodium – potassium pump in distal 
convoluted tubule and collecting duct. 
 
2. Ammonia is secreted in the proximal convolute tubule. 
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3. Hydrogen ions are secreted in the proximal and distal convoluted 
tubules.  Maximum hydrogen ion secreted in proximal tubule. 
 
Thus by the process of glomerular filtration, selective reabsorption 
and tubular secretion urine is formed in the nephron.  It is also 
concentrated by counter current mechanism and ADH.  Finally it passes 
through ureter into the urinary bladder and is stored there until it is voided 
out. 
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                                         URINARY CALCULUS 
 
Urinary calculus is stone –like body composed of  urinary salts 
bound  together  by a colloid  matrix  of organic material, it consist of 
nucleus around  which concentric layers urinary salt are deposited . 
Urinary stones have afflected humankind since antiquity, with earliest 
recorded example being bladder and kidney stones detected in Egyptian 
mummies dated to 4800 B C. 
 
Until the 1980s, urinary stones were a major problem, with a 
significant proportion of patients requiring extensive surgical procedures 
and a sizable losing their kidney. The advent of extra corporeal techniques 
for stone destruction and refinements in endoscopic surgery, however have 
greatly decreased the morbidity associated with stone surgery. 
 
EPIDEMOLOGY 
INTRINSIC FACTORS 
Hereditary 
Several disorders that cause renal stones are hereditary .Familial 
renal tubular acidosis are associated with nephrolithiosis in almost 70% of 
patients. Cystinuria, Xanthinuria and Dehydroxyadenuria are disorders 
cause renal stone 
 
Age and sex 
    The peak incidence of urinary calculus occurs in the twenties to 
forties. About three males are affected for every female because increased 
serum testosterone causes increased endogenous oxalate production in 
male, increased urinary citrate in women. 
 
EXTRINSIC FACTORS 
Geography 
 
  The prevalence of urinary calculi is higher in those who live in 
mountainous, desert, and tropical areas. 
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Climate and seasonal factors 
   Price and associates found that the incidence of urinary calculi was 
higher during the summer months. High temperatures increase 
perspiration, which may result in concentrated urine. This promotes 
increased urinary crystallization. Parry and Lister suggest that increased 
exposure of sun light cause increased production of 1, 25-dihyrdoxyvitamin 
D3 and increased urinary calcium excretion. This may cause higher 
incidence of urolithiosis in summer months. 
 
Water Intake 
Urine dilution by increased water intake may increased ion activity 
coefficients and hence urinary crystallization, water diuresis reduces the 
average time of residence of free crystal particles in urine dilutes 
components of urine that may crystals. Minerals contents of water may 
contribute to cause stone disease. (E.g. sodium chlorides) Zinc in an 
inhibitor of calcium crystallization. 
 
Diet 
         Ingestion of excessive amounts of purines, oxalates, calcium, 
phosphates, and other elements often results in excessive excretion of 
these components in urine causes increased incidence of calculi. 
 
Occupation 
         Lonsdale (1968b.c) indicated that urinary calculi are much more 
likely to be found in individuals who have sedentary occupations. The 
highest were found in cooks and engineering room personnel. The risk of 
calcium oxalate and uric acid stones formation in Astronauts because of 
hypercalciuria, hypocitraturia, decreased pH, and lower urinary volumes. 
 
PHYSICAL CHEMISTRY 
        Urinary stones do not occur unless crystals of the offending 
substance form in urine. For crystals to occur, the urine should be 
supersaturated with the salt in consideration. Increases in urinary excretion 
of chemicals that constitute the crystals result in an increased in potential 
for crystallization. Urine does not need to be continuously supersaturated 
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for crystals to form or grow: Intermittent super saturations, as is seen 
during of dehydration or after meals, is sufficient. Crystallizing potential for 
calcium oxalate is related not so much to the concentration of calcium or 
oxalate in urine but to chemical activity of ions in solution. The compounds 
such as citrate and phosphate form complexes with calcium, and elements 
such as magnesium and sodium form complexes with oxalate, effectively 
reducing the free ionic concentration of each. 
 
             Urinary crystals can be seen in most urine specimens, 
particularly after storage, yet most individuals do not form stones. Stone 
formers as a group excrete larger crystals and crystals aggregates than 
healthy individuals. Normal subjects have inhibitors of crystal formation, 
growth, and aggregation in urine such as low-molicular-weight compounds 
such as citrate and pyrophate and larger molecules, such as 
glycosaminoglycans, nephrocalcin, and Tamm – Horsfall protein.  Urine 
from patients with recurrent calcium and oxalate stones tends to have 
higher calcium and oxalate saturation and lower inhibitors than urine from 
patients without stones and a mathematically derived saturation -  inhibition 
index has been reported to discriminate between the groups with better 
than 90% accuracy. 
 
 Free crystals formed within the kidney do not have the ability to grow 
to a size large enough to occlude a collecting duct and, form a stone in a 
free – flowing urinary system.  Crystal aggregation and retention within the 
kidney are prerequisites for urinary crystals to be converted to urinary 
calculi. Crystal aggregation is enhanced in individual who lack inhibitors of 
aggregation. The urinary glycoproteins nephrocalcin and Tamm-Horsfall 
protein are potent inhibitors of crystal aggregation in simple solutions, 
whereas citrate and magnesium are inhibitors of crystal growth. 
 
 Anatomical abnormalities, such as medullary sponge kidney or 
ureteropelvic junction obstruction, or increased “stickiness” of the tubular 
epithelium can predispose to increased crystal retention.  Urate and 
calcium oxalate crystals anchsor to surrgaces of cultured renal epithelial 
cells and may adhere in vivo to tubular cells or urothelium. Although not 
 42 
proven, bacterial infection may promote calcium oxalate stone formation by 
increasing urinary matrix, which, in turn, promotes crystal adherence.  
Finally, altered transport of calcium and oxalate by renal epithelial cells 
may result in intracellular or interstitial crystallization.  These are retained in 
the kidney and can become the nidus for stone formation. 
 
TYPES OF CALCULUS 
 
CALCIUM OXALATE STONES 
        This is most common type of stones. 39% of patients are calcium 
oxalate type stone. 14% of patients are combined with calcium phosphate. 
They are irregular in shape and covered with sharp projection, which tend 
to cause bleeding. The surface of the stone is discoloured by pigments of 
altered blood. It is very hard and absorbs X-rays well. 
 
PATHOPHYSIOLOGY OF STONE FORMATION 
 
  I. HYPERCALCIURIA 
          Between 30% and 60% of all patients with calcium oxalate kidney 
stones have increased urinary calcium excretion in the absence of raised 
serum calcium levels.  Hypercalciuria has been defined as the excretion of 
greater than 4mg calcium per kg body weight per day or greater than 7 
mmol in men and 6 mmol in women (parks and Coe, 1986). Final definition 
is the excretion of urinary calcium of greater than 0.11 mg/100 ml of 
glomerular filtrate. Hypercalciuric nephrolithiasis suffer from multiple 
disturbances in renal tubular function a disturbance in phosphate transport, 
and accelerated 1, 25 – dihydroxyvitamin D3 synthesis, resulting in 
increased intestinal calcium absorption. 
 
         Hypercalciuria has three types, such as 
1. Absorptive hypercalciuria, 
2. Renal hypercalciuria 
3. Resorptive hyperclaciuria,  
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1. Absorptive hypercalciuria 
 In absorptive hypercalciuria, the primary abnormality is increased 
calcium absorption. In absorptive hypercalciuria type 1, intestinal hyper 
absorption of calcium exists, whether or not the patient is on a calcium-
restricted diet.  Intestinal magnesium absorption is normal in patients with 
absorptive hypercalciuria, but oxalate absorption is increased.  Vitamin D 
increases calcium and magnesium, but not oxalate, absorption in both the 
jejunum and ileum.  Absorptive hypercalciuria type 2 is a variant of this 
disorder wherein patient’s exhibit increased urinary calcium excretion while 
on their normal diet but normal calcium excretion on a low-calcium, low-
sodium diet.  In the final subcategory, absorptive hypercalciuria type 3, the 
serum phosphate is low, suggesting that the increased intestinal calcium 
absorption is the result of stimulation in vitamin D production as the result 
of the lowered serum phosphate. 
 
2. Renal hypercalciuria 
         In this condition, the underlying abnormality is a primary renal 
wasting of calcium. The consequent reduction in circulating serum calcium 
stimulates PTH production. Two facts must be stressed; first, intestinal 
absorption of calcium is increased in both absorptive and renal 
hypercalciuria; second, parathyroid function is suppressed in absorptive 
hypercalciuria but stimulated in renal hypercalciuria.  These two criteria 
elevated fasting urinary calcium levels and stimulated parathyroid function 
serve to distinguish renal from absorptive hypercalciuria. 
 
3. Resorptive hypercalciuria  
This syndrome is synonymous with subtle hyperparathyroidism.   
Hypercalciuria results from excessive PTH dependent bone resorption as 
well as enhanced intestinal absorption of calcium. 
 
4. Idiopathic hypercalciuria 
The syndrome of renal phosphate leak, elevated 1, 25  
dihydroxyvitamin D3, and absorptive hypercalciuria has been demonstrated 
in members of a Bedouin tribe in which intermarriage is common. Idiopathic 
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hyper calciuria may be inherited as an autosomal trait, although the pattern 
can reflect polygenic control of calcium excretion as well. 
 
II. HYPERCALCAEMIA NEPHROLITHIOSIS 
    CAUSES 
1. Primary hyperparathyroidism 
         These patients are between 39% and 78% with early presented of 
renal calculi. These patients with higher level of 1, 25-dihydroxyvitamin D3 
and greater calcium absorption tend to have renal stones. 
 
2. Malignancy associated hypercalcemia 
         Malignancy –associated hyper calciuria is an exceedingly rare cause 
of renal stones. The most common cause of malignancy- associated 
hypercalcaemia, even in patients with skeletal metastasis, is production by 
the tumour of a bone resorpting substance called PTH- related polypeptide. 
 
3. Sarcoidosis and other granulomatous diseases 
          The sarcoid granuloma produces 1, 25-dihydroxyvitamin D3, it 
causing increased calcium absorption, hypercalcaemia, and hypercalciuria. 
 
     4. Hyperthyroidism 
           About 5% to 10% of patients with hyperthyroidism develop 
hypercalcimia. Hypercalcaemia and hypercalciuria result from a stimulation 
of bone resorption mediated by thyroxine and tri-iodothyronine. 
 
5. Glucocorticoid – induced hypercalcemia 
          Glucocorticoid excess leads to increased bone resorption, decreased 
bone formation, and osteopenia. Glucocorticoid also has direct stimulatory 
effect on parathyroid gland. 
 
    6. Pheochromocytoma 
           Hypercalcaemia when seen in patients with pheochromocytoma, 
occur most often in patient with multiple endocrine neoplasma type 2, in 
which primary hyperparathyroidism, medulary carcinoma of thyroid, adrenal 
gland tumour coexit. 
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7. Immobilization 
      Prolonged bed rest can lead to hypercalcaemia, as the result of 
increased bone turnover. Hypercalcaemia is seen most often when another 
condition, such as Paget’s disease- with accelerated bone turnover-primary 
hyperthyroidism, or malignancy, coexists in an immobilized patient.  
 
III. HYPEROXALURIA 
CAUSES: 
 Primary hyperoxaluria is a rare genetic disorder resulting from 
increased hepatic production of oxalate.  Enteric hyperoxaluria occurs in 
patients with short bowel syndrome or malabsorption.  Finally, a group of 
patients with recurrent idiopathic calcium oxalate lithiasis exhibits mild 
hyperoxaluria or increased transport of oxalated by red blood cells. 
 
1. Primary hyperoxaluria  
      Two types of primary hyperoxaluria exit. Primary hyperoxaluria type1 
is an autosomal ressive inborn error of metabolism characterized by 
nephrocalcinosis and oxalosis. The diseases are characterized by 
increased urinary excretion of oxalic, glycolic, and glyoxylic acids.  Primary 
hyperoxaluria type I is due to a defect of the enzyme alanine-glyoxylate 
aminotransferase (AGT) in the liver. 
 
In normal human liver, AGT catalyzes the transamination or 
detoxification of glyoxylate to glycine, a function that it can perform only if it 
is located in the peroxisome.  Its deficiency in primary hyperoxaluria results 
in glyoxylate’s being oxidized to oxalate. 
 
 Primary hyperoxaluria type II or L-glyceric aciduria is a much rarer 
variant of the disease.  Deficiencies of the hepatic enzymes D-glycerate 
dehydrogenase and glyoxylate reductase lead to increases in urinary 
oxalate and glycerate excretion. 
 
2. Enteric hyperoxaluria 
 Ingested oxalate is absorbed through the stomach and the colon.  
Malabsorption from any cause, including small bowel resection, intrinsic 
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disease, or jejunoileal bypass, increases the colonic permeability of oxalate 
as the result of exposure of the colonic epithelium to bile salts.  
Furthermore, loss of calcium in the feces results in the presence of less 
calcium in the intestinal lumen, allowing oxalate to exist in a soluble form. 
The hyperoxaluria from small bowel malabsorption often exceeds 1 
mmol/day and causes recurrent nephrolithiasis, nephrocalcinasis, and renal 
oxalate deposition. 
 
3. Mild metabolic hyperoxaluria 
 Mild hyperoxaluria is as least as important a factor in the 
pathogenesis of idiopathic calcium oxalate stones as hypercalciuria. Baggio 
and colleagues are found an increase in oxalate self exchange across red 
blood cell membrane in 79% of patients with idiopathic calcium oxalate 
stones. The oxalate absorption was increased with increased calcium 
absorption. Dietary restriction of oxalate results in decreased oxalate 
excretion. 
 
 IV. HYPERURICOSURIA 
        Uric acid promotes calcium oxalate crystallization by facilitating the 
formation nuclei. Sodium acid urate may produce calcium oxalate stone 
disease by nullifying the effectiveness of naturally occurring inhibitors of 
calcium oxalate crystal growth. Excessive dietary intake of purine is main 
cause of hyperuricosuria. Between 80% and 90% of patients with 
hyperuricosuria nephrolithiosis are men. Patients with mixed with uric acid 
and oxalate stones have lower urinary pH than patients with pure calcium 
oxalate stones. 
 
 V. HYPOCITRATURIA 
        Hypocitraturia has been reported in 15% to 63% of patients with 
stones. Urinary citrate is normally greater in women than in men. 
Hypocitraturia define as citrate excretion of less than 0.60 mmol (115mg) in 
men and 1.03 mmol (200mg) in women. Acidosis is probably the most 
important etiologic factors in hypocitraturia. In patients with inflammatory 
bowel disease and chronic diarrhea, intestinal alkali loss results in 
metabolic acidosis. Thiazide- induced hypokalaemia and intracellular 
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acidosis are other cause of decreased urinary citrate excretion. A diet rich 
in animal protein may produce an acid load. Strenuous physical exercise 
and sodium intake can likewise produce hypocitraturia. Urinary tract 
infection with bacteria degrading citrate lowers urinary citrate excretion. 
 
The primary mechanism of action of citrate is as a complexing agent 
for calcium. Calcium citrate complexes are considerably more soluble than 
calcium oxalate. Citrate inhibits the spontaneous nucleation of calcium 
oxalate, crystal growth and aggregation of calcium oxalate and phosphate. 
 
 VI. HYPOMAGNESURIA 
 
Many experimental studies have suggested that administration of 
magnesium salts prevents stones disease. The most common cause of 
hypomagnesuria is inflammatory bowel disease associated with 
malabsorption. Most patients with hypomagnesuria also have 
hypocitraturia. 
 
 VII. SEX HORMONES AND RENAL STONES 
 
Calcium oxalate renal stones occur much more frequently in men 
than in women because increased serum testosterone levels resulted in 
increased endogenous oxalates production by liver and increased intestinal 
absorption of calcium in men, increased urinary citrate concentration in 
urine in women. 
 
CALCIUM PHOSPHATE STONES 
 
       Calcium phosphate stones composed predominantly around 10% of 
stones of renal origin. Although some amount of calcium phosphate is often 
found in calcium oxalate calculi, pure calcium phosphate stone are rare. It 
is usually smooth and dirty white, and easy to see on radiopaqhic film. 
 
Causes: 
    Renal tubular acidosis is common cause for this type of stone. Up to 
70% of adults with renal tubular acidosis have kidney stones. This stone 
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may be seen with oxalate and stuvite stones. Stone formation typically 
occurs in papillary tips and in medulla. Stone formation is result of hyper 
calciuria, hypocitraturia, and increased urinary pH.  Hypercalciuria is result 
of systemic acidosis on bone deminaralisation and secondary 
hyperthyroidism. Hypocitraturia result from a primary defect in renal tubular 
citrate transport, again, the result of metabolic acidosis. Hypocitraturia is 
probably the most important metabolic factor for stone formation in patient 
with renal tubular acidosis. The defect in proximal tubular bicarbonate 
resorption is associated with this type of stone. 
Diagnosis: the patient has hypokalaemia, hyper chloremia, metabolic  
acidosis and urinary pH of 5.5. 
 
URIC ACID STONE 
  These are hard, smooth and often multiple. Their colour varies from 
yellow to reddish brown. The pure uric acid stone are radiolusent most of 
stone with calcium so they radiolusant shadow. 
 
Causes: 
The principal cause of uric acid crystallization is supersaturation of 
urine with respect to undissociated uric acid. The normal 24-hour urinary 
uric acid excretion is between 500 and 600mg per litre of urine. Patient with 
uric acid stone often have prolonged periods of acidity in urine. The pH of 
urine in patient with uric acid stones was 5.5 ±0.4 as compared with 6.0± 
0.4 in patients who form calcium oxalate stones. Three factors are involved 
in uric acid urolithiosis. First, patients tend to excrete excessively acid urine 
at relatively fixed, low urinary pH.  Second, they may absorb, produce, or 
excrete more uric acid than patients without gout or uric acid stones.  Third, 
urinary volume is diminished in these patients.  The combination of these 
factors is ideal for the crystallization of uric acid in the urine. The frequency 
of uric acid stones in gout is about 20%.  Myeloproliferative disorders such 
as acute leukemia are an important cause of severe hyperuricosuria, 
particularly in childhood. 
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STRUVITE STONES (INFECTION STONES) 
 The stone is composed of magnesium, ammonium, and phosphate, 
mixed with carbonate.   
 
Pathogenesis 
 Two conditions must coexist for the crystallization of struvite- a urine 
pH of 7.2 or above and the presence of ammonia in the urine. A second 
mechanism by which bacterial infection may induce stone formation is by 
increasing crystal adherence. Urease producing bacteria hydrolyze urea to 
carbondioxide and ammonium molecules. Two molecules of ammonia are 
produced from one molecule of urea; neutralization of the base is 
incomplete.  As a result of this, the urinary pH rises. 
 
Clinical presentation 
 Struvite calculus accounts are the majority of staghorn stones 
observed in most countries. Thy can grow quite large and may fill the 
collecting system.  Struvite stones can form on a nidus of calcium oxalate 
stones and can grow quite rapidly.  Most infection stones are radiopaque, 
but poorly mineralized matrix stones are faintly radiopaque or radiolucent.  
Women, perhaps because of their increased susceptibility to urinary tract 
infections, are more commonly affected than men. The presence of a 
foreign body in the urinary tract and neurogenic bladder are main causes 
for struvite calculi. 
 
 Patients with struvite stones may present acutely with fever, loin 
pain, dysuria, frequency, and hematuria.  Metabolic abnormalities are 
present in patients with mixed calciumoxalate and struvite stones but not in 
patients with pure struvite stones. 
 
CYSTINE STONES  
 They are uncommon Cystine stones account for about 1% of all 
urinary calculi in the United States and occur only in patients who have 
cystinaria.  Cystinuria is an autosomal recessive disorder of 
transmembrane cystine transport manifested in the intestine and in the 
kidney.  Cystine stones are radiopaque, although less so than calcium 
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oxalated stones.  The radiopacity is the result of the disulfide bond in 
cystine.  The stones are hexagonal, translusant white colour appear in acid 
urine and it is yellowish or pinkish color when first removed but greenish 
hue color when exposed to air and have a waxy appearance and very hard.  
They are often multiple, are large, and may form staghorns.  Cystinuria can 
cause renal stones in childhood, but the peak of clinical expression is in the 
second and third decades. The cystine stones form because cystine is 
poorly soluble within the range of normal urinary pH. 
 
XANTHINE STONES 
  These are extremely rare. They are smooth and round, brick –red in 
color and a radiolucent.  Xanthinuria is an inborn error of metabolism, 
inherited as an autosomal recessive trait and characterized by a deficiency 
of xanthine oxidase.  Serum uric acid levels are low, averaging less than 
1.5 mg/dl.   Serum and urine levels of xanthine and hypoxanthine are 
significantly increased.  Xanthine stones develop because xanthine is less 
soluble than hypoxanthine. 
 
MATRIX CALCULI 
 Matrix calculi are found predominantly in individuals with infections 
caused by urease-producing organisms.  Proteus species are especially 
likely to be associated with matrix calculi.  These stone composed of 
coagulated mucoids with little crystalline component.   They are radiolucent 
and may be confused with uric acid calculi.  Their association with alkaline 
urinary tract infection, however, usually assists in making a presumptive 
diagnosis because uric acid calculi are usually formed in acidic, sterile 
urine.  Stones composed of β 2-microglobulin, a protein that is filtered and 
appears in the urine, may form in the kidneys of uremic patients. 
 
CLINICAL PRESENTATION 
 
Acute stone episode 
 A urinary calculus usually presents with an acute episode of renal or 
ureteral colic as the result of a stone obstructing the urinary tract.  There 
 51 
are five locations where stones can be impacted in the urinary tract.  First, 
stones may become impacted in calyx of the upper urinary tract.  
Symptoms are abdominal distended and painful and create hematuria.  The 
second area in which a calculus may become impacted is the ureteropelvic 
junction.  A third area of impaction is at or near the pelvic brim, where the 
ureter begins to arch over the iliac vessels posteriorly into the true pelvis.  
The fourth area, especially in females, is the posterior pelvis, where the 
ureter is crossed anteriorly by the pelvic blood vessels and by the broad 
ligament; finally, the most constricted area through which the urinary 
calculus must pass is the ureterovesical junction, which is the most 
common site of impaction. Other impaction is urinary bladder and urethra. 
 
Renal colic 
 The partially obstructing, continuously moving calculus appears to 
create the greatest amount of colic.  As the stone moves to the midureter, 
pain generally tends to radiate to the lateral flank and abdominal area.  
When ureteral stones are near the bladder, patients often develop the 
symptoms of urinary frequency and urgency. Because of the autonomic 
nervous system transmits visceral pain. Nausea and vomiting are 
commonly associated with renal colic. 
 
Physical signs 
 Pulse rate and blood pressure may be elevated because of pain and 
agitation.  Examination of the abdominal reveals moderate deep 
tenderness on palpation over the location of the calculus and the area of 
the loin. 
 
INVESTIGATION 
 Blood 
          Calcium, Phosphate, Uric acid, Urea and Electrolytes 
          Parathyroid hormone. 
Urine 
          Protein, Glucose, Blood, and Amino acid. 
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24-hr Urine examination 
         Urea, Creatinine clearance, Sodium, Calcium, Oxalate, and Uric acid. 
 
Urine culture 
Stone analysis: Chemical composition 
Plain abdominal radiograph 
Intravenous Urogram 
Computed Tomography 
Ultrasonography 
CTscan 
Modern methods of stone removal for Kidney stones: 
 
        Percutaneous nephrolithotomy, spiral CT, extracorporeal shock-wave 
lithotripsy.Open surgery for renal calculi are Pyelolithotomy, extended 
pyelolithotomy, nephrolithotomy. 
 
Treatment for Ureter calculi:  
Endoscopic stone removal, ureteroscopic stone removal and  
lithotripsy in situ. Open surgery is ureterolithotomy. 
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METERIALS AND METHODS 
 
 
1. AIMS 
a) Primary Aim 
 
               To estimate the efficacy of Kalladaippu thool in the treatment of 
Kalladaippu. 
 
b) Secondary Aim 
 
               To find out the side– effects of the trial drug, if any. 
 
2. POPULATION AND SAMPLE 
 
                The population consists of all patients with Kalladaippu 
diagnosed by clinical symptoms and Ultrasonography satisfying the 
inclusion and exclusion criteria mentioned below.  The sample consists of 
Kalladaippu patients attending the IPD/OPD of Ayothidoss Pandithar 
Hospital of the National Institute of Siddha, Chennai – 47. 
 
3. SAMPLE SIZE 
 
               The trial size will be 30 patients. 
 
4. INCLUSION CRITERIA 
 
            1. Vatha, Pittha and Khaba kalladaippu. 
 
         2. Aged between 20 and 60 years. 
 
           3. Willing to be admitted in the hospital for 8 weeks or willing to 
attend the O.P.D once a week for 8 weeks. 
 
5. EXCLUSION CRITERIA 
 
1. Severe infection 
 
2. Kidney diseases 
 
3. Diabetes insipitus 
 
4. Pregnancy 
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6. WITHDRAWAL CRITERIA 
 
1. Obstructive anuria 
 
2. Severe haematuria 
 
3. Severe pain 
 
7. TRIAL DRUG AND DURATION 
 
                Kalladaippu thool (powder) 5 g with 50 ml of raddish juice, 
 twice a day, for 8 weeks. 
 
8. CLINICAL ASSESSMENT AND INVESTIGATION 
 
a) CLINICAL ASSESSMENT 
 
     IN SIDDHA ASPECT 
 
        1. Vatha Kalladaippu: Retention of urine, lower abdominal pain with 
distention, pain with swelling of penis, agonizing pain, breathlessness and 
excretion of urine with mucus. 
 
         2. Pittha Kalladaippu: Stone blocked in urinary tract followed by 
oliguria, pain in urethra like an insertion of burning iron bar, sweating all 
over the body, anuria, agonizing pain, blood stained calculus excreted in 
urine with piercing and boring pain and hyperalgia. 
 
        3. Khaba Kalladaippu: Abdominal distention with pain like a bow, 
pain in all joints of upper and lower limbs, lumbar region, hip region and 
penis, sweating all over body and white colored stone excreted in urine. 
 
b) INVESTIGATION 
 
1. BLOOD 
  TC (cells/cumm), DC (%), Hb (g %), ESR (mm/hr),  
Blood Sugar (R) (mg %), Blood Urea (mg %), Serum Creatinine (mg %) 
and Serum Cholesterol ( mg%). 
 
2. URINE     
                        
                Reaction (pH), Albumin, Sugar and Deposits. 
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3. MOTION 
 
                Ova, Cyst, and Occult blood. 
 
4. ULTRA SONOGRAPHY 
 
5. IN SIDDHA SYSTEM 
 
                 Envagai thervukal: Naa, Niram, Mozhi, Vizhi, Malam, Moothiram 
(neerkuri and neikuri), Sparism and Naadi.          
 
9. CONDUCT 
               Kalladaippu patients satisfying the inclusion and exclusion 
criteria will be admitted to the trial. Informed consent will be obtained from 
the patients. Lab investigation will be carried out before treatment and at 
the end of the treatment. 
  
              For the I.P. patients trial drug will be administered by the doctor 
and clinical assessment will be done weekly. The trial drug will be issued to 
the O.P. patients for 7 days at a time. Patients will be asked to come for 
clinical assessment once in 7 days. Also, they will be asked to bring back 
unconsumed drug at each visit and return them. 
 
 11. FORMS      
 
             Form I:  Selection proforma - Used before admission. 
 
             Form II:  Assessment proforma – Used once in a week during  
        treatment. 
 
  12. ANALYSIS        
                       
             Paired X²– test for changes in signs and symptoms. 
 
             Paired t-test for changes in objectives parameters.  
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OBSERVATION AND RESULTS 
 
 30 cases of kalladaippu were treated with kalladaippu thool 5gms 
with 50ml raddish juice, two times for 8 weeks in NIS. The observation are 
tabulated, the patient who had positive ultrasonography, positive urine 
examination finding of crystals, R B C, albumin and puscells were included 
in this group. Tables were formed with reference of age, sex, diet history 
and personal habits seasonal incidence, distribution of land, clinical 
laboratory investigation and diagnosis. 
 
                        DISTRIBUTION OF CASES BY GENDER 
               TABLE: 1 
 
 
 
 
 
 
 
 
 
 
 
Distribution of cases by gender
70%
30%
Male
Female
 
 
                                                                                                        
 
Cases 
 
Gender 
No % 
Male 21 70.0 
Female 9 30.0 
 
Total 30 100.0 
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DISTRIBUTION OF CASES BY AGE 
                TABLE: 2 
  
Cases  
Age(yr) 
No % 
21  to 30 5 16.6 
31 to 40 11 36.6 
41 to 50 6 20.0 
51 to 60 8 26.6 
Total 30 100.0 
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DISTRIBUTION OF CASES BY AGE AND SEX 
   TABLE: 3 
 
  
 
0%
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Age in year
Age and sex distribution
Male
Female
 
                   
 
 
Cases Age(yr) 
Male 
No 
 
% 
Female 
No 
 
% 
Total  
% 
 
20 to 30 
 
3 
 
10.0 
 
2 
 
6.6 
 
5 
 
16.6 
 
31 to40 
 
9 
 
30.0 
 
2 
 
6.6 
 
11 
 
36.6 
 
41 to 50 
 
6 
 
20.0 
 
0 
 
0 
 
6 
 
20.0 
 
51 to 60 
 
3 
 
10.0 
 
5 
 
16.6 
 
8 
 
26.6 
 
Total 
 
21 
 
70.0 
 
9 
 
30.0 
 
30 
 
100.0 
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      DISTRIBUTION OF CASES BY FOOD HABITS 
                           TABLE: 4 
 
Cases Food habits 
No % 
Vegetarian 4 13.3 
Non 
vegetarian 
26 86.6 
Total 30 100.0 
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                             DISTRIBUTION OF CASES BY SEASONAL  
                    TABLE: 5 
Cases Paruvakalam 
No % 
Elavenil  kalam 
 
10 33.3 
Muthuvenil kalam 10 33.3 
Kaar kalam 8 26.6 
Koothir kalam 2 6.6 
Munpani kalam 0 0 
Pinpani kalam 0 0 
Total 30 100.0 
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  DISTRIBUTION OF CASES BY DURATION OF DISEASE 
 
 TABLE: 6 
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Duration in months Cases     No % 
0 to 3 19 63.3 
3 to 6 7 23.3 
6 to 9 2 6.6 
Total 30 100.0 
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                          DISTRIBUTION OF CASES BY THINAI 
 TABLE: 7 
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Cases Thinai 
        (Land) No % 
Kurinchi  
(Hill) 
4 13.3 
Mullai 
(Forest) 
0 0 
Marutham 
(Fertile) 
1 3.3 
Neithal 
(Costal) 
25 83.3 
Paalai 
(Desert) 
0 0 
Total 30 100.0 
 63 
 DISTRIBUTION OF CASES BY YAKKAI 
 
 TABLE: 8 
 
Cases Yakkai 
No % 
Valiazhal 24 80.0 
Azhalvali 6 20.0 
Total 30 100.0 
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 DISTRIBUTION OF CASES BY CLINICAL FEATURES 
          TABLE: 9 
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Cases S.NO Clinical features 
No % 
1 Abdominal pain 
 
30 100.0 
2 Abdominal 
distention 
1 03.3 
3 Dysuria 
 
18 60.0 
4 Oliguria 
 
16 53.3 
5 Yellowish urination 
 
18 60.0 
6 Haematuria 
 
0 0 
7 Pyuria 
 
2 06.6 
8 Nausea 
 
9 30.0 
9 Vomiting 
 
2 06.6 
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 DISTRIBUTION OF CASES BY NAADI 
                    TABLE: 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
Valiazhal
Valiiyyam
Azhalvali
Azhaliyyam
Iyyavali
Iyyaazhal
 
 
 
 
Cases Naadi 
 
 
No % 
Vali azhal 
 
24 80.0 
Vali iyyam 
 
0 0 
Azhal vali 
 
6 20.0 
Azhal iyyam 
 
0 0 
Iyya vali 
 
0 0 
Iyua Azhal 
 
0 0 
Total 
 
30 100.0 
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  DISTRIBUTION OF CASES BY NEERKURI 
 TABLE: 11 
 
Cases S.NO Neerkuri 
 
 
No % 
1 Niram 
Yellowish 
 
22 73.33 
2 Edai 
Oliguria 
 
 
21 
 
70.00 
3 Manam 
Tamarind 
 
 
2 
 
06.66 
4 Nurai 
 
1 03.33 
5 Enjal 
 
11 36.66 
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     DISTRIBUTION OF CASES BY NEERKURI 
 
                            TABLE: 12 
 
Cases Neikuri 
No % 
Vali 
 
0 0 
Azhal 
 
0 0 
Iyyam 
 
3 10.0 
Thontham 
 
0 0 
Other 
Slowly spread 
 
 
27 
 
90.0 
Total 
 
30 100.0 
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              DISTRIBUTION OF CALCULI IN URINARY SYSTEM 
 
         TABLE: 13 
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S .NO Site 
 
No % 
1 Both kidneys 
 
11 36.6 
2 Right kidney 
 
9 30.0 
3 Left kidney 
 
9 30.0 
4 Right ureter 
 
3 10.0 
5 Left ureter 
 
2 6.6 
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RESULT OF CLINICAL FEATURES AFTER TREATMENT 
TABLE: 14 
 
RESULT NO. CASES % 
GOOD 
IMPROVEMENT 
28 93.3 
MODERATE 
IMPROVEMENT 
2 6.6 
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REPORTS OF URINARY INVESTICATION 
Table: 15              
 
                                            URINE INVESTICATION 
            BEFORE TREATMENT            AFTER TREATMENT 
                 DEPOSIT                DEPOSIT 
S. 
NO 
OP.NO  
ALBU 
MIN PUS 
CELLS 
EPI 
CELLS 
CRYS 
TALLS 
ALBU 
MIN PUS 
CELLS 
EPI 
CELLS 
CRYS 
TALLS 
1 R. 8855 Nil 2 to 4 2 to 4 Nil Nil   1 to 2 1 to 2 Nil 
2 S. 359 Nil 1 to 2 1 to 2 Oxalate Nil 2 to 3 1 to 2 Nil 
3 S. 511 Nil 4 to 5 2 to 4 Nil Nil 3 to 4 1 to 2 Nil 
4 S. 2319 Nil 2 to 4 1 to 2 Oxalate Nil 1 to 2 1 to 2 Nil 
5 S. 3568 Nil 2 to 4 2 to 4 Nil Nil 1 to 2 1 to 2 Nil 
6 S. 4030 Trace 7 to 9 1 to 3 Nil Nil 3 to 5 1 to 2 Nil 
7 S. 4356 Nil 4 to 6 2 to 4 Nil Nil 3 to 4 2 to 4 Nil 
8 S. 5492 Nil 2 to 4 2 to 4 Nil Nil 3 to 4 1 to 2 Nil 
9 S. 8457 Nil 2 to 4 2 to 4 Oxalate Nil 2 to 3 1 to 2 Nil 
10 S. 9707 Nil 1 to 2 1 to 2 Oxalate Nil 1 to 2 1 to 2 Nil 
11 T. 101 Trace 2 to 4 2 to 4 Crystals Nil 4 to 5 3 to 4 Nil 
12 T.1201 Nil 2 to 4 2 to 4 Nil Nil 2 to 4 2 to 4 Nil 
13 T. 1362 + 2 to 4 2 to 4 Nil Nil 1 to 2 1 to 2 Nil 
14 T. 3053 Nil 2 to 3 1 to 2 Nil Nil 1 to 2 1 to 2 Nil 
15 T. 3220 Nil 1 to 2 1 to 2 Nil Nil 2 to3 2 to 3 Nil 
16 T. 5894 Nil 2 to 4 5 to 6 Nil Nil 2 to 4 2 to 4 Nil 
17 T. 6924 Nil 3 to 4 1 to2 Nil Nil 2 to 3 1 to 4 Nil 
18 T. 8061 Nil 2 to 4 2 to 4 Oxalate Nil 2 to 3 1 to 2 Nil 
19 T. 8379 Trace 1 to 2 1 to 2 Oxalate Nil 2 to 4 3 to 4 Nil 
20 T. 8456 Nil 3 to 4 2 to 4 Oxalate Nil 4 to 6 4 to 6 Nil 
21 T. 9592 Nil 2 to 4 1 to 2 Nil Nil 1 to 2 1 to 2 Nil 
22 U.1119 + 2 to 4 1 to 2 Oxalate Nil 2 to 4 2 to 4 Nil 
23 U.1656 Nil 3 to 3 1 to 2 Nil Nil 3 to 4 3 to 4 Nil 
24 U. 4075 Trace 5 to 6 2 to 4 Oxalate Nil 3 to 4 2 to 3 Nil 
25 U. 5278 Nil 3 to 4 1 to 2 Nil Nil 4 to 6 4 to 6 Nil 
26 U. 7537 Nil 2 to 4 2 to 4 Nil Nil 2 to 3 2 to 3 Nil 
27 U. 9107 Nil 3 to 4 1 to 2 Nil Nil 2 to 3 2 to 3 Nil 
28 V. 2027 Nil 2 to 3 2 to 3 Nil Nil 1 to 2 1 to 2 Nil 
29 V. 5386 Nil 2 to 4 3 to 4 Nil Nil 2 to 3  2 to 3 Nil 
30 V. 6251 Nil 2 to 3 1 to2 Oxalate Nil 2 to 4  2 to 4 Nil 
 
 
 
 
Out of 30 patients of urine examination 6 patients had albumin, 11 
patients had crystals and 2 patients had pus cells in urine before treatment. 
After treatment 100% patients were normal report.  
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ULTRASONOGRAPHY REPORTS IN BEFORE AND AFTER 
TREATMENT 
 
S. 
No 
O P No Name Age 
sex 
Before treatment After treatment 
1 R. 8855 Mr. Kumar 41/M 3×3 mm and 4×4 mm Sized 
calculi seen in mid calyx of 
right kidney and left kidney 
 
 
Normal report 
2 S.511 Mr. Anandan 30/M 5mm and 7mm sized calculi 
seen in upper and lower 
pole of Rt. kidney. 
7mm size calculus seen in 
upper pole of Lf. Kidney, 
7mm size in Rt. V. U.J 
 
3mm size calculus 
seen in mid pole of 
Rt. kidney. 
2mm size calculus 
seen in upper pole 
of Lt. kidney. Stone 
removed in urine. 
3 S. 2319 Mr. Rajan 
 
29/M Bilateral renal small calculi Normal report 
4 S.3568 Mr. Chandrasekar 45/M 4.4 mm and 4.7mm sized 
calculi seen in lower calyx 
and mid calyx of Lt. kidney 
with Calyceal system 
dilated. 
 
Normal study 
5 S. 4030 Mrs. Atchammal 54/F A calculus 8mm size seen 
in Rt. V.U junction with 
pelvic Calyceal system and 
Ureter dilated. 
 
Normal study 
6 S. 5492 Mr. Dhanasekar 35/M 9mm size calculus seen in  
collecting system of Lt. 
kidney 
 
4mm size calculus 
seen in Lt. kidney.  
7 S.8457 Mr. Sathish Kumar 24/M 5mm and 5mm sized calculi 
seen in upper calyx of Rt. 
kidney and Lt. kidney  
 
Normal study 
8 S. 9707 Mr. Richard 50/M 5mm and 4mm sized calculi 
seen in mid calyx of Rt. 
kidney. 5mm size calculus 
seen in lower calyx of Lt. 
kidney. 
 
4mm size calculus 
seen in mid calyx of 
Rt. kidney. 5mm 
size calculus seen 
in lower calyx of Lt. 
kidney. 
9 T. 101 Mrs. Pattammal 60/F Multiple calculi seen in mid 
pole of Rt. kidney, largest 
size 8mm. 
1.3 mm size calculus seen 
in Rt. proximal Ureter 
junction with hydronehrosis. 
 
Ureter stone moved 
to bladder. 
 
 
 
                                
10 
 
 
T.1201 Mr. Brimanaidu 41/M 5mm size calculus seen in 
lower pole of Lt. kidney 
3.2 sizes calculus 
seen in lower pole 
of Lt. kidney 
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11 T. 1362 Mr. Velraja 
 
 
60/M 5mm size calculus seen in 
Rt. kidney 
4mm size calculus 
seen in Rt. kidney 
12 T.3053 Mr. Rashid 39/M 8mm size calculus seen in 
lower calyx of Rt. Kidney 
 
Normal study 
13 T.5894 Mrs. Epsi 58/F A clump of calculi in size of 
2.3 cm seen in pelvis of Rt.  
kidney  
 
2.5 cm size calculi 
seen in Rt. kidney 
14 T.8061 Mr. Unnikrishnan 35/M Two calculi size of 5mm 
and 8mm are seen in Rt. 
mid calyx. 4mm size 
calculus seen in Rt. upper 
ureter.10 mm size calculus 
seen in Rt. V. U junction 
with Hydronephrosis  
7mm calculus seen in Rt. 
mid calyx. 
Two calculi size of 
5mm and 6mm 
seen in Rt. mid 
calyx. 4mm size 
calculus seen in Rt. 
upper calyx. 6mm 
size calculus seen 
in Lt mid calyx 
No Hydronephrosis, 
Ureter appears 
normal. 
 
15 T.8379 Mr. Lourthu mary 60/F Two calculi size of 8mm 
and 9mm seen in left lower 
calyx. 
 
Normal study 
16 T.8456 Mrs.Patchaiammal 56/F 8mm size calculus seen in 
Rt. kidney. 7 to 8mm size 
calculus seen in Lt kidney. 
 
4mm and 5mm size 
calculi seen in Rt. 
and Lt kidney. 
17 U. 7537 Mr. Sathesh kumar 
 
 
25/M 5mm and 6mm size calculi 
seen in Rt. and Lt kidney 
Normal study 
18 U. 9107 Mrs. Mushina sheri 
 
 
25/F A calculus size of 5mm 
seen in Rt. mid calyx. 
Normal study 
19 V. 6251 Mr. Durai raj 
 
 
23/M 1.5 cm size calculus seen in 
Lt lower calyx 
9mm size calculus 
seen in Lt lower 
calyx 
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1 S. 359 Mr. Ranganathan 35/M 5mm size calculus seen 
in right mid calyx. Left 
Ureter and Calyceal 
system dilated 
 
Stone 
removed 
 In urine 
on 8/12/06 
2 U. 5278 Mr. Raja 42/M 8.5 and 6mm size calculi 
seen in upper calyx of 
Rt. kidney. 5mm and 
6mm size calculi seen in 
mid and lower calyx of 
Lt kidney. 10mm size 
calculus seen in Lt mid 
Ureter. 
 
Stone 
removed 
 in urine. 
3 S.511 Mr. Anandan 30/M 5mm and 7mm sized 
calculi seen in upper 
and lower pole of Rt. 
kidney. 
7mm size calculus seen 
in upper pole of Lf. 
Kidney, 
7mm size in Rt. V. U.J 
 
Stone 
removed 
 in urine. 
4 T. 101 Mrs. Pattammal 60/F Multiple calculi seen in 
mid pole of Rt. kidney, 
largest size 8mm. 
1.3 mm size calculus 
seen in Rt. proximal 
Ureter junction with 
hydronehrosis. 
 
Stone 
removed 
 in urine. 
 
 
 
 
      19 Patients are taken ultrasonography after treatment. Among 30 
patients, in 9 patients calculi are totally reduced, in 9 patients calculi are 
reduced in size and number and one patient calculus not reduced. 
Among 30 patients, ureter stone removed in urine in 4 patients. 
9 patients are not taken U S G after treatment.  
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                                                    DISCUSSION 
 
Urinary calculus is known to mankind since antiquity. The earliest 
recorded example being bladder and kidney stones detected in Egyptian 
mummies dated to 4800 B. C.  Kalladaippu is most common disease of 
the present society. In spite of new approach in diagnosis and 
management like Percutaneous nephrolithotomy, spiral CT, extracorporeal 
shock-wave lithotripsy but it still continues to cause significant morbidity 
with high tendency of reccurrence. Kalladaippu commonly affected in 
middle and low class family, they do not do these advance procedure. 
The contribution of yoogi in the field of regional and humoral 
pathology regarding the disease kalladaippu is highly commendable. 
Siddha medicine is ancient duration system of medicine for centuries have 
provided proven treatment of disease like kalladaipu. There fore clinical 
trial was conducted on kalladaippu patients with kalladaippu thool, 30 
patients of kalladaippu patients were selected. 
 
 1. DISTRIBUTION OF CASES BY GENTER 
 The gender distribution was 2.3: 1(M: F) in total of 30 patients, 
ie.21males and 9 females because increased serum testosterone causes 
increased endogenous oxalate production in male, increased urinary citrate 
in women. 
 
2. DISTRIBUTION OF CASES BY AGE 
  A total of 30 patients of varying age group were included in this 
study, the maximum distribution of kalladaippu occurs evenly in the 31 to 
40, 41 to 50 and 51to 60 years of age groups, 25 patients were in the age 
groups(e. g) 83.3% of the total number comes under the study. Several 
authors have reported 30 to 50 years of age group as the period of 
maximum incidence of kalladaippu, these periods are mainly in pittha 
period (33.4yr to 66.4yr) of human life as per the “Rathina surukka nadi”. 
                            	 
  
  
                   -   
 
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 3. DISTRIBUTION OF CASES AMONG FOOD HABITS 
  According to table 4, 26 patients were on non vegetarian foods, 
these are induced vatham and pittham causes for kalladaippu. These food 
are having mainly protein and fat substances, it can induce humour of 
Vatham and pitham. 
 
Animal protein increase urinary calcium, oxalates and uric acid and 
decrease urinary citrates excretion in urine due to  protein contains sulphur 
contain amino acid, it increases endogenous acidosis.  
 
Excessive in take of beverage likes coffee, tea, milk and alcohol are 
induces kalladaippu because of tea contain large amount of oxalates, 
coffee increase urinary calcium excretion, milk contains large amount of 
calcium and it has lactose potent stimulator of calcium absorption. 
 
4. DISTRIBUTION OF CASES AMONG SEASON 
While distribution of kalladaippu was highest in Elavenil, Muthuvenil 
and Mazhi kalaam, out of 30 cases 28 cases belong to these periods 
because of in Elavenil kalaam iyyam comes in normal, in Muthuvenil  
kalaam vatham increased and iyyam decreased, in Mazhi kalaam pitham 
increased above in normal level. Our literature mention as Vatham and 
pittham is one main cause for kalladaippu.  
    
             “	    
            	  
 
  Price and associates found that the incidence of urinary calculi was 
higher during the summer months. High temperatures increase 
perspiration, which may result in concentrated urine. This promotes 
increased urinary crystallization. 
  . 
5. DISTRIBUTION OF CASES AMONG NILAM 
Out of 30 cases 25 belonged to neithal nilam because in our 
literature reveals this land is a place of aggravation of Vatham and also the 
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food substances obtained here containing salt. Minerals contents of water 
may contribute to cause stone disease.  
These environmental factors, diet factors and personal habits leads 
to derangement of Vatham and pitham, these humours are main 
predisposing factors for kalladaippu.  
 
6. DISTRIBUTION OF CASES AMONG NEERKURI AND NEI KURI 
On examination by envagai thervugal, the moothiram had been 
affected in all patients due to derangement of pitha kutram and abana vayu 
causing abdominal pain, yellowish urination, dysuria, Oliguria, nausea and 
vomiting. 
 
7. DISTRIBUTION OF CASES AMONG CLINICAL FEATURES 
 As per the above data 100% of patients were affected abdominal 
pain and above 50% of patients were affected by yellowish urination, 
dysuria and Oliguria, after treatment abdomen pain relieved in 93.3% of 
patients, where other symptoms were relieved in 100% of patients. 
The presence of albumin, crystals and pus cells come down to 
normal under treatment with trial drug in 100% of cases. 
 
8. ULTRASONOGRAPHY REPORT 
Out of 30 cases 19 patients were taken ultrasonography, after 
treatment with trial drug with in 8 weeks of periods, stone completely 
dissolved in 9 patients, ureter stone removed in urine in 4 patients and 
stone reduced in size and numbers in 9 patients. Other 9 patient’s clinical 
symptoms were totally reduced. 
 
9. BIOCHEMICAL STUDY 
 
Potassium: 
 The trial drug having potassium salts, these are good diuretics and 
reduce urinary excretion of calcium and kidney stone recurrence. 
Potassium citrate prevents upper urinary tract calculi this proved by 
Lee YH, HuangWc and Tsai JY in J. urology.1999 may: 161. 
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Citrates: 
 The drugs having Citrates  is most important complexor of calcium in 
urine and reduce ionic calcium concentration, sodium citrate salts mixed 
with alkaline salt of trial drug causes metabolic alkalosis decrease 
mitochondrial uptake of citrate and increase urinary citrate excretion that 
prevention of recurrent calcium oxalate stones. 
 
Magnesium: 
 Magnesium salts produce more favorable Magnesium to calcium 
ratio in urine in condition that offers relative protection against stone 
formation. Magnesium decrease renal tubular citrate resorption through the 
chelatoin of citrate and this increase urinary citrate excretion in urine. It 
salts lowered the relative saturation urine with calcium oxalate or brushite. 
 
Phosphate: 
 Phosphates were used in the hope of binding dietary calcium in the 
intestinal thus reducing its absorption. Urinary phosphorus excretion is 
markedly increased during therapy with alkaline phosphate which results in 
an increasing in the inhibitor activity of calculus in urine perhaps because of 
increased renal excretion of pyrophosphate and citrate.  
 
Zinc: 
 The potent inhibitory effect of urinary zinc excretion on urolithiasis  
evaluated in urologia internationalis 2004: 72:233-236.  
 
10. PHARMACOLOGICAL STUDY:   
 
      Test drug kalladaippu thool (1000mg/kg/p.o) was given in water 
the diuretic activity was not significant at the end of 5 and 10 hrs when 
compared to urea (1000mg/kg/p.o). 
 
 However an enhanced diuresis was observed when test drug 
kalladaippu thool was along with radish juice with a Lipschits value more 
then 1 at the end of 5 and 10 hrs of examination. 
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11. ACUTE ORAL TOXICITY STUDY: 
 
 Kalladaippu thool at the dose of 2000 mg/kg/po did not exhibit any 
mortality in rats. As per the OECD 423 guideline the dose is said to be 
Unclassified under the toxicity scale. 
 
12. TREATMENT: 
 
 All ingredients of trial drug are having diuretic and lithotriptic effects, 
they were prepared as per the formula seen in the Siddha literature. 
 
13. A Patients were advised to take plenty of water and asked to follow 
strict diet restriction during and after treatment to prevent the recurrence of 
stones. 
 
14. The clinical study was hope encouraging. This is only preliminary 
approach and study may be undertaken with the same drug in large 
number of patients, which may prove to be more effective in treatment. 
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SUMMARY 
 
 The clinical trial was conducted in 30 patients of renal calculus with 
trial drug of kalladaippu thool in dose of 5gms twice a day with 
adjuvant of 50ml raddish juice.  
 
 Clinical diagnosis of kalladaippu was done in the basis of clinical 
features described in our text book.  
 
 Urine and haematological examination and ulrasonography were 
done before and after treatment of trial drug. 
 
 The various Siddha aspect examinations were carried out and 
recoded. 
 
 Kalladaippu in Siddha aspect was correlated with urinary calculus 
in modern aspect. 
 
 In biochemical study the trial drug had magnesium, potassium, 
citrates and tannin.Which are confirmed the clinical prognosis in 
renal calculus. 
 
 In pharmacological study showed that the trial drug had well diuretic 
action without adverse effect in dose of one gram per kg. 
 
 The medicine chooses for clinical treatment and management of 
kalladaippu by kalladaippu thool. 
 
 Observation of the trial drug in the clinical study was clinically 
effective. 
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                                       CONCLUSSION 
 
 The clinical trial of kalladaippu thool was conducted in 30 patients for 
8 weeks of period. 
 
 In the study 93.3 % of patients were clinically good improvement and 
6.6% were moderate in improvement with trial drug. There were no 
clinically significant adverse reactions noted with trial drug.  
 
 In Siddha and modern aspect of urine investigation in all patients after 
treatment came down to normal. 
 
 Out of 30 patients, 19 patients were taken ultrasonography after 
treatment, among 19 patients, stone dissolved completely in 47.3 %( 9) 
and reduced size and number in 47.3 %( 9) of patients. Among 30 
patients ureter stone removed in 13.3 %( 4) with short period of 
treatment.  
 
 In biochemical study the drug has potassium, magnesium, citrates and 
tannin were confirmed. This helps in clinical prognosis of renal calculus.  
 
 The diuretic action of the trial drug had very good efficacy with 
anubanam in animal study and without toxic effect.  
 
 Expenditure of the trial drug is low in cost and easily preparable but 
highly efficacy in kalladaippu.  
 
 The clinical study was encouraging to do the deep study in large sample 
of kalladaippu patients with trial drug with proper diagnosis. 
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PREPARATION AND PROPERTIES OF TRIAL DRUG 
 
KALLADAIPPUTHOOL (	
) 
 
INGREDIENTS  
 
1.  (Ash of Achyranthus aspera) -2 palam (70gms) 
2. 	
 (Ash of Plantain barks) -2 palam (70gms) 
3. 	  (Ash of Palm flowering stalks) -2 palam (70gms) 
4.  (Ash of tried Brinjal’s plants) -2 palam (70gms) 
5.  (Powder of Pale catechu) -2 palam (70gms) 
6.  (Purified Borax powder) -2 palam (70gms) 
7.  (Purified Alumen) -2 palam (70gms) 
8.  (Purified Rock salt) -2 palam(70gms) 
9.  (Purified Sodium carbonates) -2 palam(70gms)  
    
METHOD OF PREPARATION  
    Above all ingredients were taken in to equally and made powder form by 
rock mortar.  
   
DOSAGE: 5gms (1 to 1.5 varagan eadai), twice a day for 8 weeks. 
 
ADJUVANT: 5oml of Raddish juice 
 
MEDICINAL USES: Urinary calculus, anuria, burning micturition, urethral 
stricture and tumor in urinary tract.  
 
                        -  ,  ,  76. 
                                              - .   ! "# $ 
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1. (ACHYRANTHUS ASPERA) 
 
Family:         Amarantheseae 
Part of uses: Whole plants  
Taste:           Bitter, pungent and astringent, 
Potency:      Heat 
Pirivu:          Pungent 
Action:         Astringent, diuretic and alterative 
 
 (Therapeutic effects) 
 
         %#&' !$() * &"  + 
       #,# -&.  */. 0'1  
       #2 3$&4 ()& 562 7 ,# 
       #* 1()8 1'9 . & : 
                                                                                - (.1) 
Medicinal uses: 
 
                Decoction of whole plants is good diuretics in renal calculus. 
It contains a large percentage of alkaline ash and it mainly contains potash 
salt. Decoction of whole plants is a good diuretic found efficacious in renal 
dropsies and general anasarca. 
 
 Ashes of plants with water, jaggery cures dropsies such as 
anansarca, ascites.                
                -Indian materia medica,   by.Dr.K.M.Nadkarni. 
 
 It is useful in renal and vesical calculi, flatulence, colic, painful 
inflammation, dropsy, and vomiting.                                                                                                                                                             
              - Indian medicinal plants, Volume-1.  Vaidyaratnam, P.S.Varier’s. 
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2.  (MUSA PARADISIACA) 
 
Family:          Mimosaceae 
Part of uses: Fruit, leaves and stems 
Taste:           Astringent 
Potency:       Cold 
Pirivu:           Pungent 
Action:          Styptic, anti Vatha, diuretic, refrigerant and astringent. 
 
 (Therapeutic effects) 
          %<* 1)*9 "##+1 
     < 2+1 =# 8"# 
     & &9 =&&4+7 
      60&> 1.=&:    - (.1) 
 
 
Medicinal uses: 
It cures ascites, burning micturition, haematuria and abdominal ulcer.   Its 
salt is a diuretic and lithotriptic action, it prepared from plantain bark ashes. 
Plantain ash contains phosphoric anhydride, lime, alkalies, iron, and 
chlorine etc. 
 
         Ash of husk of ripe fruit contains carbonates of potash and soda, 
chloride of potassium, alkaline phosphates with alittle sulphate, lime, silica, 
earthy phosphates etc. Ashes produced by burning the plant contain 
potash salt and are therefore useful in acidity, heartburn and colic.  
It ashes is a potash salt uses for nephritis, uraemia and ascities. 
                             -Indian materia medica By Dr.K.M.Nadkarni. 
 
    The ashes obtained by burning plant are anti scorbutic, anthelmintic, and 
stomachic, and are useful in hyperacidity, heartburning, colic, and 
verminosis. The inflorescence axis (stem) is very specific for renal and 
vesical calculi.     
                                    -Indian medicinal plants, Vaidyaratnam, P.S.Varier. 
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3.   (BORASSES FLABELLIFER) 
 
Family:          Palmaecae 
Part of uses: Root, flowering stalk, juice, bark and fruits.  
Taste:           Astringent 
Potency:       Cold 
Pirivu:           Sweet 
Action:          Astringent, diuretic, demulcent, nutritive and refrigerant. 
 
 (Therapeutic effects)   
  %7?2 @#  '0 1 
    762 *A+ AB 77 
    7C <1 <D5&! B 
     7 7 )$: - (.1) 
 
 Medicinal uses:  
It cures vayu gunmam, burning micturition, dental disease and 
chronic fever. Ashes of flowering stalk are diuretics. Salt prepared from 
ashes of flowering stalk diluted with water then filter it pure ash less diluted 
water exposure to sun light.     It contains albuminoids gum and fat.  Juice 
is diuretics, cooling, stimulant, and antiphlogestic.   
 It uses for dropsy and inflammatory condition.  Ashes of flavoring 
stalk are useful in enlarged spleen.                
     - Indian materia medica                                                                 
                                                                 By.Dr. K.M.Nadkarni. 
 
The ash obtained by burning the inflorescence is good antacid, 
antiperiodic, and useful in hyperacidity, heartburn, biliousfever, 
splenomegaly, hepatomegoly, and skin diseases. 
                                              - Indian medicinal plants, volume-1 
                                                              Vaidyaratnam, P.S.Varier’s. 
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4. 	 (SOLANUM MELONGENA)  
 
Family:          Solanaceae 
Part of uses: All parts of plant   
Taste:            Bitter and astringent 
Potency:        Heat 
Pirivu:            Pungent 
Action:           Stimulant, hypnotic and cxpectorant. 
 
 (Therapeutic effects)  
 
      %&C ' 70. * B 
       = =0&' E3B =/. 
       D7 &C 5 +1 
        D* 1<# 8 : - (.1) 
 
Chemical constituents: 
     Dried material contain ether extract 4.2 p.c.,  albuminiods 
16.37p.c.,  nitrodgen 2.62p.c., soluble carbohydrate 55.23 p.c.,  woody fibre 
17pc ash 7.20p.c. 
 
 Ripe ones are carbonesanous and bilias.  Burnt fruits are like in 
digestion, purgative, slightly cilious and beneficial in phlegm, wind and 
obesity.                                             
                                                          -Indian materia medica 
 
   Medicinal uses: It leaves used in diuretic drugs. 
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5. 	 (UNCARIA CAMBIR) 
 
Family:         Rubiaceae 
Part of uses: Stem   
Taste:  Bitter astringent 
Potency:  Heat 
Pirivu:  Pungent 
Action:  Astringent. 
 
 (Therapeutic effects) 
 
         %2 *AB => C &> 
          ? F.!$ F 7" 
          ='1F =# *. B .21 
           G."  *H  
                            -  * 1> ),  
                                            . !().  
 
 
Medicinal uses: 
It cures diarrhea, anuria, oral ulcer, burned ulcer, blood diseases 
and increase concentration of semen. 
It contains the active principle- Catechu- tannic acid 22 to 50%p.c, 
catechine 7 to 33 p.c., quercetin, a yellow – colouring principle, catechu- 
red, gambier- fluorescein, wax and oil etc. 
                            -Indian materia medica    by. Dr.K.M.Nadkarni 
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5.  (SODIUM BIBORATE) 
 
It is composed of boric acid and soda. 
Taste:      Sweet with astringent.   
Potency:  Heat  
Pirivu:       Pungent  
Action:     Astringent, diuretic, antacid, local sedative, antiseptic and     
                emmenagoge.  
  
 (Therapeutic effects) 
 
         %=0$+ = 1 & 
      0&> "I7 7C =0 
               +'>' 'F *!+D . 
      +'>' #6 =: 
                                         -Siddha materia medica 
 
Purification: 
It fried by heat, still water contents removal.  
 
Medicinal uses: 
         It cures scabies, eight types of gunmam, giddiness, dysentery, urinary 
calculus, burning micturition, dental diseases, worm’s infection, snake 
poison and epilepsy. 
 
Vengara parpam cures pitha diseases like burning micturition and 
kalladaippu. 
 
Borax is given orally in dose varying from 10 to 30 grains in acidity of 
stomach, dyspepsia and intestinal organism. It commonly mixed in 
decoction for kalladaippu.  
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6.  (ALUMEN) 
 
Characters:  
It is colorless, transparent crystals, with acid. Alum is a general 
name for a class of double sulphates containing aluminium and such 
metals as potassium, ammonium, iron, etc. 
Taste:        Sweetish astringent   
Potency:    Heat  
Pirivu:        Pungent  
Action:      Astringent, diuretic, haemostatic and anti spasmodic.  
 
   (Therapeutic effects) 
 
     %7= &  0F "#&>  
       J7" >C 7#=B #" 
        ' 4 # -()<# 
                1 1=7 G2: 
                                                   -Siddha materia medica 
 
Purification:  
It makes in to power form and mixed with water then boiled well up 
to solid consistence and tried with sun light. 
 
Medicinal uses: 
It cures gingivitis, fileriasis, eye diseases, heart diseases, Vatham, 
fever, peptic ulcer and tumor. Padikara parpam has been used for urinary 
calculus, urethral stricture, anuria and burning micturition. 
                                                         –Siddha materia medica.  
 
It is useful in leucorrhoea, haematuria, haemoptysis, menorrhagia, 
gastric and intestinal catarrh and other haemorrhages. 
                                      -Indian materia medica, by.Dr.K.M.Nadkarni.   
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7.  ! (SODIUM CHLORIDE IMPURA) 
 
Character: 
 It is found in small white crystalline grains or transparentcubes. It is 
brownish white externally and white internally. It has apure saline taste and 
burns with a yellow flame Taste:     Salt in tast.   
Potency: Heat  
Pirivu:     Pungent,  
Action:    Diuretic, laxative, carminative and stomachic. 
 
 (Therapeutic effects) 
 
      %A+ 1 . *&DK* . 
        A+ 3!$ ++'( =A+# 
        AB+ . C &! 
        AB+ . ! (H 
                                       -Siddha materia medica 
 
Purification: 
 It maked in to powder form, mixed with anna kaadineer, kept in to 
the sun light for three Dayes, then washed with fresh water and tried with 
sun light. 
 
Medicinal uses: 
It cures eight types of gunmam, dyspepsia, kaba pitham, tumour, 
three thosam, constipation, poison, sukila noi and eczema. 
 
In small dose it is highly carminative, stomachic and digestive. It 
possesses stronger purgative property. -Indian materia medica 
                                                               By.Dr. K.M.Nadkarni. 
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8. #$ (SODIUM CABONATE) 
 
% /&D =!$ L 
       @7* * =39&. 
C=3&6 53+ C9 
                           M& => 3  -FA3+ 
-FA3 & N /& 
                           FA3BD & A3 =BB 
FAB(  &0  
                           =FAB & ( 3: 
                              97 800  24 
 
Medicinal uses sowkaram was prepared by fuller earth, pooneeru, 
potassium nitrates and lime. 
 
: (Therapeutic effects) 
        %*  *!+4 A3 &!+ 
         * S06 08#F * 
           =A3 F T0 60B 
          A39 /&' : 
                                          -  * 1> ),  
                                                        . !().  
 
Fuller earth is one of the ingredients of sowkaram so it has same action. 
Constituents: Fullar earth contains 25 p.c. of sodium carbonate with certain 
impurities such as organic matter, sulphate of soda, potash. 
Action: It is antacid, alterative, and diuretic. 
 
Medicinal uses: 
     It is useful in dyspepsia with vomiting, diarrhea, and flatulanse. It is 
efficient remedy in urinary diseases as uric acid, gravel and suppression    
 of urine.     
                                 -Indian material medica by.Dr.K.M.Nadkarni. 
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ADJUVANT: 
RADDISH JUICE (RAPHANUS SATIVAS, Linn): 
 
Family:         Cruciferae 
Part of uses: All parts of plant   
Taste:           Pungent 
Potency:       Cold 
Pirivu:           Pungent 
Action:          Diuretic, Laxative. Stimulant, Stomach and Aphrodisiac 
: (Therapeutic effects) 
 
            	
   
                 !" 
            
# 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$  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            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"$*  + 
                                                       -Siddha materia medica 
 
Constituents: 
Fresh vegetable contain 91.00 p.c of moisture. 
Completely tried material contain etherextract-4.00p.c,  
Albuminoids-18.00p.c, Solublecarbohydrates-52.66p.c,  
Woody fibre- 9.34 p.c, and Ash-16.00 p.c.  
Seeds and wood contain fixed oil and sulphureted volatile oil  
 
Medicinal uses: 
Root juice given for urinary complaints like dysurea and strangury. 
                                                    -Indian materia medica                                   
                                                      By.Dr. K.M.Nadkarni. 
 
Root juice 34ml to 100ml is increased urination. 
Root is contains rich in vitamin C and E it increase immunological and 
antibacterial activity of white blood cells by increasing their motility. 
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QUALITATIVE ANALYSIS OF ACIDIC/BASIC RADICALS AND 
PHYTOCHEMICALCONSTITUENTS IN TEST DRUGS 
Procedure Observation inference 
Test for Calcium: 
2 ml of extract is taken in a 
clean test tube. To this add 2 
ml of 4% ammonium oxide 
solution. 
 
 
White precipitate is 
formed 
 
 
Presence of calcium 
Test for Sulphate : 
2 ml of the extract is added 
to 5 % barium chloride 
solution. 
 
White precipitate is 
formed 
 
Presence of Sulphate 
Test for Chloride :  
The extract is treated with 
Silver nitrate solution 
 
White precipitate is 
formed 
 
Presence of Chloride 
Test for carbonate : 
 The substance is treated 
with Conc. HCl. 
 
Effervescence is 
formed 
 
Presence of carbonate 
Test for Starch : 
 The extract is added with 
weak iodine solution 
 
Blue colour is not 
formed 
 
Absence of starch 
Test for Iron (Ferric) :  
The extract is treated with 
glacial acetic acid and 
potassium ferrocyanide 
 
Blue colour is formed 
 
Presence of Ferric iron 
Test for Iron (Ferrous) : 
The extract is treated with 
Conc. HNO3 and ammonium 
thiocynate 
 
No Blood red colour is 
formed 
 
Absence of Ferrous 
iron 
Test for phosphate :  
The extract is treated with 
 
Yellow precipitate is 
 
Presence of phosphate 
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ammonium molybdate and 
conc. HNO3 
formed 
Test for Tannic acid : 
 The extract is treated with 
Ferric chloride 
 
Blue black precipitate 
is formed 
 
Presence of Tannic 
acid 
Test for Unsaturation : 
 1 ml of Potassium 
permanganate solution is 
added to the extract. 
 
 
Does not get 
decolourised 
 
Absence of 
unsaturated compound 
Test for saponins:  
Dilute extract + 1ml of 
distilled water and shake 
well. 
 
Froth formation 
 
Presence of saponins 
Test for sugars : 
Benedict method ; 
 5ml of Benedict solution 
heated gently then add 8 
drops of diluted extract then 
heated in a boiling water 
bath. 
Molisch test;  
Dilute extract + 2 drops of 
Molisch+3ml conc.H2SO4. 
 
No colour change 
 
 
 
 
 
No Reddish violet 
zones appeared 
 
Indicates the Absence 
of sugar 
 
 
 
 
Absence of 
carbohydrate 
Test for steroids :  
Liberman Burchard test; 
 Dilute extract + 2 ml acetic 
anhydride + conc.H2SO4. 
 
 
No Formation of red 
colour 
 
Absence of steroids 
Test for amino acids: 
Dilute extract + 2ml of  
Ninhydrin’s soln. 
 
Formation of  violet 
colour 
 
Presence of  amino 
acids 
Test for proteins:  
Biuret method ; 1ml of dilute 
 
Formation of Violet   
 
Presence of proteins 
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extract + 1mlof 5%CuSO4  + 
1%NaOH. 
colour 
Test for Flavanoids : 
 Dilute extract + 2drops of 
conc.HCl and gently heated. 
 
 
No formation of pink 
colour 
 
Absence of Flavanoids 
Test for phenol; 
 Dilute extract+2drops of 
FeCl3 soln. 
 
 
Deep green colour is 
formed 
 
Presence of phenols 
Test for Tannins; 
 Dilute extract + 2ml of 
 10%lead acetate adds. 
 
 
White precipitate 
formed 
 
Presence of tannins 
Test for alkaloids; 
 Mayer’s method; 1ml of 
dilute extract + 1ml reagent. 
 
Dragendroff’s method; 1ml of 
dilute extract+ 1ml of 
reagent. 
 
 
No appearance of 
cream colour 
precipitate 
 
 
No appearance of 
orange colour 
precipitate 
 
 
Absence of alkaloids 
 
 
 
 
Absence of alkaloids 
Citrate: 
2 ml dilute extact add 0.5ml 
of silphuric acid, and 3 ml of  
KMNO4 warm until the 
colour of KMNO4 is 
discharged and add 10% of 
sodium nitro preside in 1M of 
sulphamic acid make in to 
alkaline with strong ammonia 
 
 
 
 
Violet colour turns in to 
violet in blue. 
 
 
 
 
Presence of  citrate 
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solution. 
 
Magnesium: 
2ml dilute extract of sample + 
1ml of diluted ammonia 
 
 
White precipitate 
formed 
 
Presence of 
magnesium 
 
Ammonia: 
2ml dilute extract of sample 
add with 2M NAOH and 
0.3ml of potassium tetra 
iodomercurate solution and 
allowed stand for 5 minutes.   
 
Yellow colour 
developed 
 
Presence of 
ammonia 
 
Zinc: 
2ml dilute extract of sample 
add with 1.5 ml of 2 M Hcl, 
5ml of distilled water and 
diluted sodium hydroxide. 
 
 
White precipitate 
formed 
 
Presence of Zinc 
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1.0 MATERIALS AND METHODS 
 
 
1.1 Test Drugs 
 
 The test drug used in the study was processed by the methods 
prescribed in standard text books of siddha medicines. 
 
1.1 Kalladaippu thool  
Kalladaippu thool was prepared by the method described in 
Anuboga vaidhya navaneetham 9th part, page no.72. 
 
1.2 Preparation of drug for dosing 
 
 Drug used for the study was suspended each time with 1% (w/v) 
solution of sodium carboxy methyl cellulose before administration. 
 
1.3 Drugs and chemicals 
 
 Fine chemicals used in these experiments were obtained from 
Sigma Chemicals Company, U.S.A. Other analytical grade chemicals were 
obtained from S.d. Fine Chemicals Ltd., Mumbai. 
 
1.4 Experimental animals  
 
 Colony inbred wistar rats of either sex weighing 200 - 250 g were 
used for the pharmacological and toxicological studies. The animals were 
kept under standard conditions 12:12 (day/night cycles) at 220C room 
temperature, in polypropylene cages. The animals were fed on standard 
pelleted diet (Hindustan Lever Pvt Ltd., Bangalore) and tap water ad 
libitum. The animals were housed for one week in polypropylene cages 
prior to the experiments to acclimatize to laboratory conditions. The 
experimental protocol was approved by the Institutional Animal Ethical 
Committee (IAEC). 
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1.5 Acute oral toxicity study     
 
Acute oral toxicity was conducted as per the OECD guidelines 
(Organization of Economic Cooperation and Development) 423 (Acute 
Toxic Class Method). The acute toxic class method is a stepwise procedure 
with 3 animals of a single sex per step. Depending on the mortality and /or 
moribund status of the animals, on the average 2-4 steps may be 
necessary to allow judgment on the acute toxicity of the test substance. 
This procedure results in the use of a minimal number of animals while 
allowing for acceptable data based scientific conclusion. 
 
The method uses defined doses (5, 50, 300, 2000 mg/kg body 
weight) and the results allow a substance to be ranked and classified 
according to the Globally Harmonized System (GHS) for the classification 
of chemicals which cause acute toxicity 
 
 
Wistar albino rats of either sex weighing 200-250 g were fasted 
overnight, but allowed water ad libitum. Since the formulation is relatively 
non toxic in clinical practice the highest dose of 2000 mg/kg/p.o (as per 
OECD guidelines “Unclassified”) was used in the acute toxicity study.   
 
The animals were observed closely for behavioural toxicity, if any by 
using FOB (Functional observation battery). 
 
1.6 Diuretic activity in rats (Lipschitz test) 
 
A method for testing diuretic activity in rats has been described by 
Lipschitz et al., 1943. The test is based on urine excretion in test animals 
and compared to rats treated with a high dose of urea. The “Lipschitz 
value” is the quotient between urine excretion by test animals and urine 
excretion by the urea control.  
 
Male wistar rats weighing 150-200 g were used. Three animals per 
group are placed in metabolic cages provided with SS wire mesh bottom 
and funnel to collect the urine. SS sieves are placed on the funnel to retain 
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feces and allow the urine to pass. The animals were fed with standard 
pelleted diet and water ad libitum. 15 hrs prior to the experiment food and 
water were withdrawn. The animals were divided into 4 groups with 3 
animals in each group and the following regimen of treatment was 
instituted.        
 
Group I Control (Radish juice) 5 ml/per animal 
Group II Urea (Standard) 1g/kg/p.o 
Group III Test drug in water 1000 mg/kg/p.o 
Group IV Test drug (1000 mg/kg/p.o) in radish juice  
                       (5ml/per animal) 
 
 
For screening procedures 2 groups of three animals were used for 
the study. The test drug Kalladaippu thool and standard drug urea were 
administered orally at the doses of 1g/kg, respectively. Additionally 5 ml of 
0.9% sodium chloride per 100 g body weight was given by gavage. Urine 
excretion was recorded after 5 and 10 hrs. 
 
Urine volume excreted per 100 g body weight was calculated for 
each group. Results are expressed as “Lipschitz value” ie, the ratio of 
test/urea. Indices of 1.0 and more are regarded as a positive effect.  
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2.0 Results 
 
2.1 Preliminary basic, acidic radicals and phytochemical studies   
 
The qualitative chemical analysis and acidic, basic radical’s assay of 
the drugs showed the presence of phytoconstituents and minerals as 
depicted in (Table 1). 
 
2.2 Acute oral toxicity study 
 
Kalladaippu thool at the dose of 2000mg/kg/po did not exhibit any 
mortality in rats. As per OECD 423 guidelines the dose is said to be 
“Unclassified” under the toxicity scale. Hence further study with higher 
doses was not executed.  
 
2.3 Diuretic study 
 
In the diuretic study there was no significant diuretic activity was 
observed when radish juice alone is given at the end of 5 and 10 hrs 
observation. Where as urea (1 g/kg/p.o) showed significant diuretic activity 
at the end of 5 and 10 hrs of observation. When the test drug Kalladaippu 
thool (1000 mg/kg/p.o) was given in water the diuretic activity was not 
significant at the end of 5 and 10 hrs when compared to standard urea 
(1g/kg/p.o). However an enhanced diuresis was observed when the test 
drug Kalladaippu thool was given along with radish juice with a Lipschitz 
value more than 1 at the end of 5 and 10 hrs of observation. This study 
clearly establishes the enhanced diuretic activity of Kalladaippu thool 
when it was given with radish juice as “anupanam”. The animals received 
radish juice alone (5 ml/per animal) did not exhibit significant diuretic 
activity.  
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Discussion 
 
The Kalladaippu thool is said to be clinically useful siddha 
formulation for diuresis. In the present study the acidic and basic radicals 
and phytochemical studies revealed the presence of K+, Na+, Ca++, Fe+++, 
Mg++, Zn++, Sulphate, Chloride, Carbonate, Phosphate, Citrate, Ammonium 
radicals and phytoconstituents like tannins, tannic acid, phenols etc. 
 
In clinical practice the drug is given at the divided doses of 10 g/day 
in radish juice. The radish juice is used as “anupanam” for enhancing the 
absorption and bioavailability of the test drug. Administration of radish juice 
alone did not exhibit any significant diuretic activity but when co 
administered with Kalladaippu thool exhibited significant diuretic activity. 
Similarly Kalladaippu thool administered in water did not exhibit significant 
diuretic activity when compared to standard drug urea.            
 
The “Lipschilz value” of present study shows a pi/U ratio of more 
than one (1) which is considered to be a significant index to rate a drug as 
diuretic.  
 
There is good correlation in diuretic activity of Kalladaippu thool in 
both clinical and experimental study when co-administered with radish 
juice. The presence of Na+ and K+ ions and other basic and acidic radicals 
present in the formulation may be responsible for the diuretic activity of 
Kalladaippu thool. The exact mechanism of diuretic action of Kalladaippu 
thool should be investigated further.       
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Table  
 
Diuretic activity of Kalladaippu thool in rats 
 
   
 
Groups  5 hrs 10 hrs 
Control 
(Radish) 
0.7167±0.2927 2.017±0.4070 a 
Urea (std) 1.33±0.1751a 3.333±0.3882 a,c 
Test drug 
(water) 
1.23±0.28 a,b 1.367±0.1633 a 
Test drug 
(radish) 
1.733±0.2066 a,d,e 3.550±0.2811 a,d,e 
 
 
n = 6, values are expressed as mean ± S.D followed by One way Anova 
using Turkey’s multiple comparison method. 
P<0.001 was considered significant. 
ap< 0.001, bp< 0.01, cp<0.001, dp>0.05, ep<0.001 
a -  all groups vs control  
b,c - test (water) vs standard 
d - test (radish) vs standard 
e - test (water) vs test (radish) 
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NATIONAL INSTITUTE OF SIDDHA, 
CHENNAI 47 
  
AN OPEN TRIAL OF KALLADAIPPU THOOL FOR THE 
TREATMENT OF KALLADAIPPU (URINARY CALCULUS) 
 
FORM-I   SELECTION PROFORMA 
 
 
1. O.P.No / I.P No:  ________ 2.  Bed No: ________   3. S.No: ________    
 
4. Name: ________________   5. Age (years): __ 6. Gender:  M F 
 
7. Occupation: ____________________  
 
8. Address: _________________________________________________                                                
     ________________________________________________________                                                      
                                                                        
                                                              
9. COMPLAINTS AND DURATION:  _____________________________ 
     _________________________________________________________ 
 
 
10. HISTORY OF PRESENT ILLNESS:  __________________________ 
      ________________________________________________________                     
      ________________________________________________________ 
 
 
      PAST HISTORY    
                                                     1. Yes        2. No                                                                        
11. Renal tubular obstruction:              
 
 
12. Recurrent renal calculus:                                     
 
 
13. Prolonged immobilization:                                  
  
 
14. Kidney transplantation:                
 
 
15. Healed renal tuberculosis:                    
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      ENDOCRINE DISORDERS 
                                                                          1. Yes           2. No    
16. Hyper parathyroidism:                       
 
 
17. Cushing syndrome:  
                    
     CONGENITAL DISORDER HISTORY 
                                                                          1. Yes           2. No       
 
18. Medullary sponge kidney:                                        
 
19. Myelo proliferative disorder:                                  
  
      TREATMENT HISTORY 
                                                                          1. Yes           2. No 
20. Oral diuretics:                                          
 
21. Non- steroid anti- inflammatory drugs:              
 
22. Sugery for urinary calculus:                     
 
23. Extra carporeal shock wave lithotripsy:                                
 
       FAMILY HISTORY 
                                                         1. Yes       2. No 
24. Gout:                     
 
25. Cystinuria:                             
 
26. Xanthinuria:               
 
      DIET HISTORY   
                                                          
      Vegetarian foods                               1. No             2.Yes        
 
27. High intake of dairy products:       
 
28. Low calcium diet:                                  
 
29. Nuts               
         
  Non- vegetarian foods  
            
30. Meat:              
 
31. Poultry:                
 
32. Fish:          
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      Drinks                                                   
 
33. Alcohol:                                      
 
34. Tea:                    
 
35. Coffee:              
 
35. Milk:    
                   
         GENERAL EXAMINATION 
 
 
37. Weight (kg):                                                    
        
38. Temperature (°F):                                           .      . 
  
39. Pulse rate / minute:                                          
 
40. Heart rate / minute:        
 
41. Respiratory rate / minute:                              
   
42. Blood pressure (mmHg):                               /       / 
 
                                                 1. Yes              2. No 
43. Anaemia:                                 
 
44. Jaundice:                      
 
45. Cyanosis:  
           
46. Lymphadenopathy:  
  
47. Pedal oedema:  
  
48. Clubbing:                                
 
49. Jugular vein pulsation:            
 
     VITAL ORGANS EXAMINATION: 
 
                                    1. Normal         2. Affected 
50. Heart                            __________________ 
 
51. Lungs                             _________________ 
 
52. Brain                            __________________ 
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53. Liver         ________________ 
 
54. Kidney                                  __________________ 
 
55. Spleen                         __________________ 
 
56. Stomach                               __________________ 
 
57. Urinary bladder                    __________________ 
 
     CLINICAL EXAMINATION 
 
     SIGNS AND SYMPTOMS 
 
58. Abdominal pain               1. No     2. Yes 
 
59. Severity:   0. NA      1. Mild    2.  Moderate  
 
      3. Severe 
 
60. Sites: 0. NA    1. Loin    2. Renal angle  
 
      3. Lower abdomen    
 
61. Radiating areas:  0. NA  1. Groin   
 
   2. Thigh  3. External Genitalia  
                            1. Yes                2.No 
 
62. Abdominal distention           
        
63. Dysuria                     
      
64. Oliguria                         
    
65. Yellowish urination                   
 
66. Haematuria                        
    
67. Pyuria   
      
68. Nausea                         
 
69. Vomiting                               
   
70. Fever       
 
71. Sweating                                   
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      SIDDHA SYSTEM OF EXAMINATON 
 
      IYMPORI 
                                      1. Normal        2. Affected 
  
72. Mei            _____________________ 
 
73. Vaai              ______________________ 
 
74. Kan              _____________________ 
 
75. Mookku                        _____________________ 
 
76. Sevi                        _____________________ 
 
    KANMENTHIRIUM  
   
  
77. Kai     _____________________ 
 
78. Kaal       _____________________ 
 
79. Vaai        _____________________ 
 
80. Eruvai        ____________________ 
 
81. Karuvaai        _____________________ 
 
 
82. PARUVA  KAALA 
 
 
     1. Elavenil kalam      2.Muthuvenil kalam 
  
    3. Mazhai kalam      4. Kulir kalam  
  
   5. Munpani kalam           6. Pinpani kalam     
 
83. THINAI 
 
      1. Kurunji      2. Mullai             3. Marutham     
 
      4. Neithal        5. Palai 
      
 
84. YAKKAI 
   1. Vali       2. Azhal        3. Iyam     
  
     4. Valiazhal    5. Valiaiyam           6. Azhalvali   
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    7. Azhaliyam     8. Iyavali          9. Iyaazhal  
  
     10. Mukkutram          
                                            
 85. GUNAM 
 
    1. Sathuva gunam            2. Rajo gunam         
 
     3. Tamo gunam 
      
     UYIR THATHUKKAL 
     VALI     
                                        1. Normal       2. Affected 
 
86. Pranan                                  _____________________ 
 
87. Abanan                                  _____________________ 
 
88. Samanan                                    _____________________ 
 
89. Udhanan                                  ______________________ 
 
90. Viyanan                                    _____________________ 
 
91. Nagan                                    _____________________ 
 
92. Koorman                                    ______________________ 
 
93. Kirukaran                                  _____________________ 
 
94. Devathathan                              ______________________ 
 
95. Tananjeyan           _____________________ 
  
    
    AZHAL 
                                   1. Normal          2. Affected 
 
96. Anala pittham   ______________________ 
 
97. Prasaka pittham         _____________________ 
 
98. Ranjaka pittham                                  ____________________ 
 
99. Aalosaka pittham             ______________________ 
 
100. Saathaka pittham              ______________________  
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IYAM 
                                     1. Normal          2. Affected                                     
 
101. Avalambagam          ______________________ 
 
102. Kilethagam                                            ________________________  
 
103. Pothagam               ______________________ 
 
104. Tharpagam               _______________________    
 
105. Santhigam          ______________________ 
 
        UDAL THATHUKKAL 
                                    1. Normal         2. Affected 
106. Saaram                _______________________ 
 
107. Chenneer                                                 _______________________ 
 
108. Oon                     __________________________ 
 
109. Kozhuppu                   _______________________ 
 
110. Enbu                      _______________________ 
 
111. Moolai                                   ________________________ 
 
112. Sukkilam /             ________________________ 
        Suronitham 
 
  ENVAGAI THERVUKAL 
 
                                    1. Normal        2. Affected 
113. Naa                                      ______________________ 
 
114. Niram                                  ______________________ 
 
115. Mozhi                             ______________________ 
 
116. Vizhi                             ______________________   
 
        Malam        1. Normal       2. Affected     
117. Niram               _______________________ 
 
118. Thanmai          ______________________ 
    
     Moothiram    
        Neerkuri   
119. Niram                  ______________________ 
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120. Eadai                                         _____________________ 
                                
                                      1. No                2. Yes 
121. Manam               _______________________  
 
122. Nurai                 _______________________ 
 
123. Enjal                   _______________________ 
 
 
124. Neikuri:  1.Vatham          2. Pittham         3. Khabam      
            
          4. Kalappu kuttram      5. Mukkuttram 
    
   
125. Sparisam:  1.Mithaveppam        2.Miguveppam         
                    
                 3.Thatpam 
 
126. Naadi:   1.Vatham     2.Pittham             3.khabam         
   
   4.Vathapittham        5. Vathakhabam          6. Pitthavatham   
  
   7. Pitthakhabam         8. Khabavatham        9. Khabapittham    
  
   10. Mukkuttram 
 
       INVESTIGATION 
       BLOOD 
 
127. TC (cells /cumm): 
 
     DC (%):128. P              129. L               130. E              131. B                  
 
132 M.                       
 
133. Hb (gms %):                
 
        ESR (mm/hr):  134. 1/2hr                     135.1hr 
 
136. Blood Sugar (R) (mg %): 
 
137. Blood Urea (mg %): 
 
138. Serum Creatinine (mg %):              . 
  
139. Serum Cholesterol (mg %): 
 
 111
      URINE 
 
140. Reaction:   1. Acid        2. Alkaline 
   
141. Albumin:   0. Nil       1. Trace       2. +            3. + + 
  
     4. + + +    
                                                                                                                                                                 
142. Sugar:  0. Nil          1. Trace           2. +              3. + +         
 
     4. + + + 
         
Deposit                  1. Yes          2. No 
 
143. Pus cells                       
 
144. Epithelial cells             
 
145. RBC                               
 
146. Crystals                             
  
        MOTION                         
                                  1. Yes         2.No    
147. Ova                           
 
148. Cyst                          
 
149. Occult blood              
 
150. ULTRA SONOGRAPHY:                       
        _________________________________________________ 
        _________________________________________________ 
       __________________________________________________ 
        __________________________________________________ 
 
 
151. ADMITTED TO TRIAL:     1.Yes          2. No   
    If yes   
 
152. S. No:    
                 
153. I.P / O.P       1. I.P        2. O.P  
 
154. Drug issued for OP patient (g): 
 
155. Station                                          57.   Signature of Medical Officer 
 
156. Date:                                                                                      
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AN OPEN TRIAL OF KALLADAIPPU THOOL FOR THE 
TREATMENT OF KALLADAIPPU (URINARY CALCULUS) 
 
FORM II- ASSESSMENT PROFORMA 
 
1. O.P.No / I.P No:  ________         2.  Bed No: ________            3. S.No:     
  
4. Name: ____________________    
 
      
5. Date of admission to the trial: 
 
6. Date of assessment: 
 
7. Week of assessment: 
 
   CLINICAL ASSESSMENT      
 
   SIGNS AND SYMPTOMS   
                                                                         
 8. Abdominal pain          1. No     2. Yes 
 9. Severity:     0. NA     1.  Mild      2.  Moderate       3. Severe 
10. Sites: 0. NA      1. Loin    2. Renal angle   3. Lower abdomen    
11. Radiating areas:  0. NA     1. Groin     2. Thigh   
                           3. External Genitalia    
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                        1. Yes                2.No 
12. Abdominal distention                     
13. Dysuria                            
14. Oliguria                             
15. Yellowish urination               
16. Haematuria                                  
17. Pyuria                           
18. Nausea                          
19. Vomiting                                  
20. Fever                                  
21. Sweating                                             
     INVESTIGATIONS (only at the end of treatment) 
     BLOOD 
 
22. TC (cells /cumm): 
 
  DC( %):  23. P                24. L               25. E               26. B                27. M                       
 
28. Hb (gms %):                                 . 
 
       ESR (mm/hr):                         29. 1/2hr                        30.1hr 
 
31. Blood Sugar (R) (mg %): 
 
32. Blood Urea (mg %): 
 
33. Serum Creatinine (mg %):                               . 
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34. Serum Cholesterol (mg %): 
 
       URINE 
35. Reaction:   1. Acid        2. Alkaline    
36. Albumin:   0. Nil 1. Trace  2. +  3. + +  4. + + +   
37. Sugar:  0. Nil  1. Trace      2. +    3. + +   4. + + + 
 
       Deposit      
                                   1. Yes          2. No 
38. Pus cells                        
39. Epithelial cells              
40. RBC                                  
41. Crystals                              
  
      MOTION                                               
                                         1. Yes          2.No    
48. Ova                             
49. Cyst                           
50. Occult blood              
 
51. ULTRA SONOGRAPHY:                                                
           _________________________________________________________ 
        ___________________________________________________________ 
        ___________________________________________________________ 
        ___________________________________________________________ 
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      INVESTICATION IN SIDDHA SYSTEM  
 
      NEERKURI        1.Normal      2.Affected 
42. Niram                 ______________________________  
43. Edai                   ______________________________ 
     1.  No              2. Yes 
44. Manam                ______________________________ 
45. Nurai                   _____________________________ 
46. Enjal                   _____________________________ 
 
47. Neikuri:  1.Vatham                2. Pittham                  3. Khabam      
                        4. Kalappu kuttram      5. Mukkuttram      
   
 
52. Drugs returned (capsules): 
                 
 
53. Drugs issued (capsules): 
                
 
 54. Station: _____________    
                                                                                       
                                                                          56.  Signature of the Medical Officer 
 55.  Date: _____________ 
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CONSENT FORM 
 
                                         Certificate by Investigator 
 
    I certify that I have disclosed all details about the study in the terms 
really understood by the patient. 
 
Date: _____________ 
                                                            Signature: ________________ 
Station: ___________ 
                                                            Name: ____________________ 
 
                                                
 
 
Consent by Patient 
 
  I have been informed to my satisfaction, by the attending physician, the 
purpose of the clinical trial, and the nature of the drug treatment and follow-
up including the laboratory investigations to be performed to monitor and 
safeguard my body functions. 
 
  I am aware of my right to opt out of the trial at any time during the course 
of the trial without having to give the reasons for doing so. 
 
  I, exercising my free power of choice, hereby give my consent to be 
included as a subject in the clinical trial of Kalladaippu Thool for 
Kalladaippu. 
 
  Date: _____________                                            
                                                           Signature: _________________ 
  
Station: _____________                      Name: ___________________ 
 
                                                  Signature of witness: _____________ 
 
 
Date: ____________                          Name: ___________________   
   
Station:  ___________                   Relationship: _________________ 
     
 
 
 
URINARY CALCULUS REMOVED IN URINE 
 
 O. P NO: U5278,   Name: Mr. Raja 
 
 
 
 
                           O. P. No: T101, Name: Mrs. Pattammal 
 
 
 
                           O. P. No: S. 359, Name: Mr. Ranganathan 
  
 
 
                          O. P. No: S. 511, Name: Mr. Anandan 
 
 
                   ACHYRANTHUS ASPERA         
                     
                     
                   
                    ASH POWER OFACHYRANTHUS ASPERA         
 
 
 MUSA PARADISIACA 
 
 
 
 ASH POWDER OF MUSA PARADISIACA 
 
 BORASSES FLABELLIFER 
 
 
 
 ASH POWDER OF  BORASSES FLABELLIFER 
 
 
 SOLANUM MELONGENA 
  
 
 ASH POWDER OF  SOLANUM MELONGENA 
  
                   UNCARIA CAMBIR 
 
 STEM 
 
 POWDER FORM OF UNCARIA CAMBIR 
 
  
 
 
 
 
 
 
 
 ALUMEN 
 
 
 
 PURIFIED ALUMEN 
 
 
  
              SODIUM CHLORIDE IMPURA 
 
 
 PURIFIED SODIUM CHLORIDE IMPURA 
 
  
 
               PURIFIED SOWKARAM 
 
 
 KALLADAIPPU THOOL 
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